The persistence of recombinant adenoviral vectors by Jäger, Lorenz
   
   
Max-von-Pettenkofer-Institut für Hygiene und Medizinische Mikrobiologie  
        Lehrstuhl Virologie 
    Direktor: Prof. Dr. U. Koszinowski 
        
 
 
 
 
 
 
 
   
  The persistence of recombinant adenoviral vectors 
 
 
 
 
         Dissertation zur Erlangung des Doktorgrades der Naturwissenschaften 
    der Fakultät für Biologie  
      der Ludwig-Maximilians-Universität München 
 
 
   
 
 
 
 
                    von 
 
                                                                Lorenz Jäger  
 
                                                                 
 
 
 
 
 
     eingereicht im 
    Dezember 2008 
 
 
 
 
 
   
 2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Tag der mündlichen Prüfung: 4.5.2009 
 
Erster Gutachter: Prof. Dr. Heinrich Jung 
Zweiter Gutachter: Prof. Dr. Ruth Brack-Werner 
Sonderberichterstatter: Prof. Dr. Ulrich Koszinowski 
 
 
 
 
 
 
 
 
   
 3 
  Table of contents 
 
Abbreviations                  8 
Summary               10 
Zusammenfassung              12 
 
A Introduction             14 
 
1.1 Properties of human adenoviruses and adenoviral infections        14 
1.2 Adenoviral genome organisation and replication         16 
1.3 Adenoviral vectors for gene therapy           16 
1.3.1 First generation adenoviral vectors          17 
1.3.2 Gene-deleted adenoviral vectors           17 
1.3.2.1 Immune response against gene-deleted adenoviral vectors      18 
1.3.2.2 Long-term persistence of recombinant adenoviral vectors      19 
1.3.2.3 Previous work on the persistence of recombinant adenoviral vectors     19 
1.3.2.4 Potential mechanisms of persistence and molecular conformations of 
recombinant adenoviral vectors           20 
 
Aims of this work              23 
 
B Material and Methods           24 
 
1. Material               24 
   1.1 Plastic ware              24 
   1.2 Chemicals and enzymes            24 
   1.3 Equipment              24 
2. Viruses, viral vectors, oligonucleotides, plasmids and bacteria        25 
   2.1 Viruses and viral vectors            25 
   2.2 List of oligonucleotides            25 
   2.3 Plasmids              26 
   2.4 Bacteria               27 
3. Bacterial media, strain cultivation, storage and antibiotics        27 
4. Molecular genetic methods            28 
   
 4 
   4.1 Plasmid Mini-Preparation            28 
   4.2 Determination of the DNA concentration          28  
   4.3 Electro-transformation of bacteria           29 
   4.4 Manipulation of plasmid DNA           29 
4.4.1 Restriction digestion of DNA and agarose gel electrophoresis      29 
4.4.2 Isolation of DNA fragments from agarose gels        29 
4.4.3 Dephosphorylation of DNA fragments         29 
4.4.4 Ligation of DNA fragments and plasmids         30 
   4.5 DNA-Sequencing and bioinformatic analysis         30 
   4.6 Isolation of DNA from eukaryotic cells          30 
4.6.1 Isolation of genomic DNA from cell pellets         30 
4.6.2 Isolation of low molecular weight DNA from eukaryotic cells      31 
4.6.3 Isolation of genomic DNA from liver          31 
   4.7 Pulsed Field Gel Electrophoresis (PFGE)          32 
   4.8 Southern blotting             32 
4.8.1 Southern transfer of agarose gels          32 
4.8.2 Southern blot hybridisation/Labelling of the probe        32 
4.8.3 Probes used for Southern hybridisation         33 
4.8.4 Stripping of hybridised Southern membranes        33 
   4.9 Analysis of RNA             33  
4.9.1 Isolation of RNA            33 
4.9.2 Reverse Transcription of mRNA into cDNA/Analysis of cDNA by PCR     33 
   4.10 Polymerase chain reactions (PCR)           34 
4.10.1 Standard PCR             34 
4.10.2 PCR for concatemer and circular monomer detection       34 
4.10.3 Real-time PCR for detection of XhoI-cleavage/GD AdV-replication     34 
5. Enzyme activity assays             35 
5.1.1 Luciferase assay in vitro           35 
5.1.2 Luciferase life imaging           35 
   5.2 Measurement of alanine aminotransferase (ALT)/Analysis of hepatic injury     35 
   5.3 Enzyme Linked Immunosorbent Assay (ELISA)         36 
6. Cell culture              36 
   6.1 Cell culture media             36  
6.1.1 Cultivation of eukaryotic cell lines          37 
   
 5 
6.1.2 Establishment of cell cultures from cryostocks        37 
6.1.3 Preparation of permanent cell culture stocks in liquid nitrogen      38  
6.1.4 Passaging of eukaryotic cell lines          38 
6.1.5 Establishment of stable eukaryotic cell lines         38 
   6.2 Gene-deleted adenoviral vector hFIX (GD AdV)         38 
   6.3 Large-scale production and purification of viral vectors and viruses      39 
6.3.1 Pre-amplification steps           39 
6.3.2 Large-scale production of GD AdV          39 
6.3.3 Large-scale production of Ad5 wt, ∆E4 mutants and 1st generation vector     40 
6.3.4 Purification of adenoviruses and adenoviral vectors       40 
   6.4 Adenovirus DNA analysis            41 
   6.5 Titering of adenoviral vector preparations          41 
6.5.1 Determination of the physical titre          41 
6.5.2 Determination of the infectious titre by Southern blot       42 
6.5.3 Determination of the infectious titre by quantitative real-time PCR     42 
6.5.4 Determination of the helper virus contamination of GD AdV preparations   43 
7. Transduction of cell lines             43 
8. Animal studies              43  
   8.1 Transduction of C57Bl/6 mice with GD AdV ApoE HCR hAAT hFIX      44  
9. The model transgene human blood coagulation factor IX        44 
 
C Results              45 
    
   1.1 Analysis of tropism and persistence of rAdV in vivo         45 
1.1.1 Generation of a luciferase-expressing GD AdV        45 
1.1.2 Investigation of tropism, transduction efficacy, transgene expression  
        and persistence of GD AdV employing luciferase life-imaging      46 
   1.2 Do gene-deleted adenoviral vectors (GD AdV) replicate?        46 
   1.3 Establishment of the methylase/restriction endonuclease-based system      48 
1.3.1 Construction of the PaeR7 methyl transferase expression plasmid  
         pIRESpuro2 PMT             48 
1.3.2 Generation of stable cell lines for PaeR7 methyl transferase expression     49 
1.3.3 Evaluation of PMT-functionality in 116M and 293M cells       49 
1.3.4 PMT-methylation is removed by replication         54 
   
 6 
   1.4 The replicative state of GD AdV genomes in vitro         55  
   1.5. The replicative state of GD AdV genomes in vivo         56 
1.5.1 Investigation of the replicative state of GD AdV genomes in vivo by     
         conventional PCR            58 
1.5.2 Analysis of the replicative state of GD AdV genomes in murine liver by  
         real-time PCR             60 
 
   2.1 Do rAdV form concatemers and/or circles?          62 
2.1.1 Detection of ∆E4 concatemers in PFGE         63 
2.1.2 Analysis of concatemer formation of GD AdV in PFGE       64 
2.1.3 Discrimination between GD AdV genomes and helper virus genomes     66 
   2.2 PCR assay for detection of linked adenoviral vector genomes       66  
2.2.1 Determination of the detection limits of this PCR system       67 
2.2.2 Analysis of the ∆E4 concatemers obtained by PCR        68 
2.2.3 Sensitivity assay for concatemer and control-of-infection PCRs      68 
   2.3 Investigation of concatemer and circle formation in GD AdV and ∆E1/E3 AdV  
         genomes in cell culture            70 
   2.4 Analysis of the molecular status of GD AdV genomes in quiescent and cycling cells  
         in vivo.                72 
 
D Discussion             74 
 
   1.1 GD AdV genomes are not replicated in vitro and in vivo        75 
   1.2 rAdV genomes do not form concatemers or circles         77 
 
E References             81 
F Appendix              91 
 
1. Molecular size marker             91 
2. Characterisation of virus and vector preparations         91 
   2.1 Determination of infectious titres and total genomes by real-time PCR      91 
    
   
   
 7 
 2.2 Determination of the helper virus contamination in GD AdV preparations by   
          quantitative PCR             92 
   2.3 Comparison of the infectious titre of ∆E4 mutants and GD AdV by Southern blot   92 
3. Establishment of a PCR assay for detection of circular GD AdV genomes      93 
4. Plasmid maps              95 
 
Publications               96 
 
Acknowledgements              97 
 
Erklärungen               98 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  Abbreviations 
 8 
Abbreviations 
 
Ad5 wt   Adenovirus serotype 5 wild type 
ADP     Adenovirus death protein 
Ad-Pol   Adenoviral polymerase 
Ads    Adenoviruses 
AdV    Adenoviral vector 
ALT    alanine transferase 
AmpR    Resistance against ampicillin 
ApoE    Apolipoprotein E 
bp    Base pairs 
CAR    Coxsackie B and adenovirus receptor 
cDNA    Complementary DNA 
CIP    Calf intestine phosphatase 
dATP    Desoxy adenosine triphosphate 
DBP    DNA-binding protein 
dCTP    Desoxy cytidine triphosphate 
dGTP    Desoxy guanosine triphosphate 
DNA    Desoxy ribonucleic acid 
dNTPs    Desoxy nucleoside triphosphates (dATP, dCTP, dTTP, dGTP) 
dTTP    Desoxy thymidine triphosphate 
DMSO   Dimethyl sulfoxide 
ds    Double-stranded 
DSBR    Double-strand break repair 
EDTA    Ethylene diamine tetra acetic acid 
FBS    Foetal bovine serum 
GD AdV   Gene-deleted adenoviral vector 
hAAT    Human alpha-1-antitrypsin 
HCR    Hepatic control region 
hFIX    Human blood coagulation factor IX 
HR    Homologous recombination 
HRP    Horseradish peroxidase 
ITR    Inverted terminal repeat 
KanR    Resistance against kanamycin 
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kb    Kilo base pairs 
LB    Luria Bertani 
luc    Luciferase 
MAR    Matrix attachment region 
MCS    Multiple cloning site 
MOI    Multiplicity of infection (vp/cell) 
mRNA   Messenger RNA 
NF    Nuclear factor 
NHEJ    Non-homologous end joining 
OD260    Optical density at 260 nm 
ORF    Open reading frame 
ori    Origin of replication 
PBS    Phosphate-buffered saline 
PCR    Polymerase chain reaction 
PFGE    Pulsed field gel electrophoresis 
p.i.    post infection 
pRb    Retinoblastoma tumour suppressor protein 
pTP    Preterminal protein 
rAdV    Recombinant adenoviral vectors 
RNA    Ribonucleic acid 
RLU    Relative light units 
SDS    Sodium dodecyl sulphate 
SV40    Simian virus 40 
TAE    Tris-acetate-EDTA 
TBS    Tris-buffered saline 
TBS-T    TBS-Tween 20 
TE    Tris-EDTA 
TP    Terminal protein 
TRIS     Tris-(hydroxymethyl)-ammonium methane 
vp    Viral particles 
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Summary 
 
 
Recombinant adenoviral vectors (rAdV) are commonly used as gene transfer vehicles and in 
gene therapy. Recombinant first generation vectors lack the early genes E1 and E3 (∆E1/E3) 
which makes way for insertion of up to 8.2 kb of foreign DNA. Gene-deleted adenoviral 
vectors (GD AdV) lacking all viral coding sequences contain only the inverted terminal 
repeats (ITR) and a packaging signal at its genomic termini. Hence, there is space for the 
insertion of coding sequences of up to 36 kb of therapeutic transgenes and additional 
sequences that could stabilise the vector DNA in mitotic cells. Multiple studies for liver-based 
gene transfer demonstrated that non-integrative rAdV result in long-term phenotopic 
correction and are maintained life-long in mice and for up to 2 years in rats, dogs and non-
human primates. In concordance with these reports, transgene expression in mice was also 
seen for several months in the present study. Therefore, it is likely that rAdV provide 
mechanism(s) leading to persistence in mitotic host cells.  
However, the mechanisms responsible for vector genome maintenance are unknown. Thus, 
some of the mechanisms that might mediate the persistence of rAdV genomes in vitro and in 
vivo were analysed. 
 
In the present study, episomal replication of GD AdV genomes was tested by a 
methylase/restriction endonuclease-based system. High-titre preparations of methylated GD 
AdV were produced and tropism and persistence of transgene expression in murine liver were 
analysed. It was found that the originally transduced GD AdV genomes are the persistent 
DNA molecules in vitro and in murine liver. Therefore, replication does not influence the 
persistence of GD AdV genomes. 
Furthermore, concatemer as well as circle formation of ∆E1/E3 and GD AdV genomes were 
analysed in cell culture experiments and in the liver of mice. For these investigations, pulsed 
field gel electrophoresis and polymerase chain reaction assays were employed. These 
experiments showed that - unlike ∆E4 mutant adenovirus that is characterised by 
concatemerisation - rAdV genomes are exclusively present as linear monomers. Hence, the 
persistence of rAdV genomes is independent of concatemeric and circular conformations. 
Notably, the molecular analysis of ∆E4 mutant concatemers showed the diversity of 
concatemeric junctions. All possibilities of end-junctions were found having various deletions 
at the connected genomic termini of ∆E4 virus. 
 
  Summary 
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Taken together, the present study provided evidence that GD AdV genomes persist as 
replication-inactive linear monomers. 
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Zusammenfassung 
 
Rekombinante adenovirale Vektoren (rAdv) sind verbreitete Gentransfervehikel für die 
experimentelle Gentherapie. Rekombinanten Vektoren der ersten Generation fehlen die 
frühen Gene E1 und E3 (∆E1/E3), was die Einfügung fremder DNS bis zu einer Größe von 
8,2 kb ermöglicht. Gendeletierte adenovirale Vektoren (GD AdV) besitzen keinerlei virale 
DNS-Sequenzen außer den invertierten terminalen Wiederholungssequenzen (ITR) und ein 
DNS-Verpackungssignal. Deshalb können in das Genom von GD AdV therapeutische 
Transgene und zusätzliche Genom-stabilisierende DNS-Elemente von bis zu 36 kb eingebaut 
werden. In zahlreichen Studien wurde gezeigt, dass ein Transgen von solchen nicht 
integrierenden rAdV längere Zeit exprimiert wird und dass die DNS von rAdV in Ratten, 
Hunden und Affen bis zu zwei Jahre lang persistiert. In Übereinstimmung mit diesen Studien 
konnte auch in der vorliegenden Arbeit eine Transgenexpression von rAdV für mehrere 
Monate beobachtet werden. All diese Daten deuten darauf hin, dass rAdV Mechanismen 
aufweisen, die zur Persistenz des Vektorgenoms in sich teilenden Wirtszellen führen. Solche 
Mechanismen, die für die Aufrechterhaltung des Vektorgenoms verantwortlich zeichnen, sind 
bisher allerdings nicht beschrieben worden. Deshalb wurden einige dieser möglichen 
Mechanismen in vitro und in vivo untersucht. 
 
In der vorliegenden Arbeit wurde die episomale Replikation von GD AdV mittels eines 
Methylase/Restriktionsendonuklease-basierten Ansatzes getestet. Hochtitrige Stammlösungen 
eines methylierten GD AdV wurden hergestellt und sowohl Tropismus als auch persistente 
Transgenexpression wurden in der Mausleber untersucht. Es konnte gezeigt werden, dass die 
ursprünglich transduzierten Vektorgenome ohne Replikation in vitro und in der Mausleber 
persistieren. Die Persistenz GD AdV wird deshalb nicht durch Replikation vermittelt. 
Außerdem wurde die Bildung von konkatemeren und zirkulären ∆E1/E3 und GD AdV 
Genomen in Zellkultur und in der Mausleber untersucht. Dafür wurden 
Pulsfeldgelelektrophorese (PFGE) und Polymerasekettenreaktionen (PCR) eingesetzt. Diese 
Experimente zeigten, dass – im Gegensatz zur ∆E4 Virusmutante, die starke 
Konkatemerbildung ausweist – rAdV Genome als lineare Monomere in der Wirtszelle 
vorliegen. Deshalb ist die Persistenz rAdV Genome unabhängig von zirkulären und 
konkatemeren DNS Konformationen. 
Ferner zeigte die molekulare Analyse der Konkatemere von ∆E4 Virusmutanten, dass die 
Verknüpfungspunkte zwischen den Konkatemeren vielfältige Deletionen aufweisen.  
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Zusammenfassend hat die vorliegende Studie gezeigt, dass rAdV Genome als nicht 
replizierende, lineare Monomere persistieren. 
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A Introduction 
 
 
1.1 Properties of human adenoviruses and adenoviral infections 
 
Adenovirus was first discovered in adenoids of a patient with persistent infection in 1953 
(Rowe et al. 1953). Adenoviruses (Ads) are non-enveloped, icosahedral viruses with a capsid 
of 70 to 90 nm in diameter. The viral capsid consists of three major proteins: hexons, pentons 
and knobbed fibers [figure 1]. The linear double-stranded DNA (dsDNA) of Ad varies 
between 25 and 40 kb (Stewart et al. 1993, Russell 2000). Covalently bound to both 5’ ends is 
a terminal protein (TP) that plays a unique role in viral DNA replication (Rekosh et al. 1977). 
Besides Ads that are pathogenic for humans, Ads can also infect animal hosts like mammals 
and birds. Currently, 51 human Ad serotypes are identified by immunological means and 
classified into 6 subgroups (A – F) (De Jong et al. 1999). Subgroup C adenoviruses include 
Ad serotype 5 (Ad5) that is the most extensively characterised serotype.  
Ad5-derived vectors are widely used as gene therapeutic vehicles in gene therapy. Due to 
their tropism Ads predominantly infect epithelial cells of the respiratory and gastrointestinal 
tracts and the conjunctiva. In natural infections subgroup C Ads (e.g. Ad5) enter their host 
cells by receptor mediated endocytosis. The fiber proteins of the capsid bind to coxsackie B 
and adenovirus receptors (CAR) on the cell surface and bring the penton proteins close to 
integrins in the plasma membrane. The internalised viral particle escapes from the endosome 
and is subsequently transported to the nucleus via the cytoskeleton. Having reached the 
nucleus, the viral genome is released from the capsid and amplification of progeny virus is 
started. The newly generated virus is released by lysis of the host cell (Shenk 1996). 
In immunocompetent patients, Ads typically cause acute, self-limiting and non-persistent 
diseases like rhinitis, pharyngitis, gastroenteritis, diarrhoea and conjunctivitis. In patients with 
compromised immune status, however, primary adenoviral infections may lead to 
disseminated, life-threatening complications (Horwitz 1996; Cichocki et al. 2008). Moreover, 
the high incidence of adenoviral infections in organ transplant recipients (kidney, bone 
marrow and liver) and AIDS patients implies that these onsets very likely represent 
reactivations of latent/persistent adenoviral infections. If the infection is not yet controlled by 
the host immune system, Adenoviruses are able to persist for years in adenoids and tonsils or 
are excreted via the faeces for several months (Humar et al. 2006; Lee et al. 2008; Michaels et 
al. 1992; McGrath et al. 1998; Hierholzer 1992).  
  Introduction 
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Figure 1: Adenoviral structure. The capsid proteins represent the main structural proteins; 
the core proteins are DNA-binding proteins stabilising and packaging the viral genome within 
the capsid shell. The cement proteins reinforce the virion’s structure and tie the viral DNA to 
the capsid sheath. TP = terminal protein. See text for details. Reprinted from Russell 2000. 
  Introduction 
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1.2 Adenoviral genome organisation and replication 
 
The double-stranded linear genome of adenoviruses is an example for efficient genomic 
organisation within limited space. Open reading frames (ORFs) coding for proteins that play a 
specific role during the viral replication cycle are grouped together. The adenoviral genome 
can be divided into early transcription units (E1, E2, E3 and E4) and late transcription units 
(L1, L2, L3, L4 and L5) [figure 2A]. The early ORFs encode effector enzymes that promote 
viral replication, the late ORFs code for structural proteins that are assembled to the capsid. 
The proteins of early transcription units (I) establish a beneficial environment for viral 
replication (E1), (II) start and accomplish viral DNA replication (E2), (III) protect against 
host cell defence (E3) and (IV) shut down cellular protein expression and promote viral 
growth (E4). E1 forces the host cell from G1 to S phase by binding to the retinoblastoma 
tumour suppressor (pRb) and p53. E1 is also a transactivator of other viral genes and is 
involved in viral mRNA transport and inhibits apoptosis (Lewin 1991; Steegenga et al. 1998; 
Chinnadurai 1998; With 1998; Perez and Withe 1998). The E2 proteins are necessary for viral 
genome replication: for example, the preterminal protein (pTP) acts as a primer for the 
adenoviral DNA polymerase (Ad-Pol)(Hay et al. 1995; Ramachandra and Padmanabhan 
1995; Van der Vliet 1995). E3 prevents the transport of major histocompatibility complex I 
(MHC-I) molecules to the cell surface (Wold et al. 1995; Wold et al. 1999). E4, whose 
promoter activity is enhanced by E1, inhibits cellular protein expression and prevents 
concatemer formation by interacing with the double strand break repair system (DSBR) of the 
host cell (Akusjärvi 1993; Dobbelstein et al. 1997; Krätzer et al. 2000; Horridge and Leppard 
1998; Gabler et al. 1998). At the end of the adenoviral replication cycle the genome is 
packaged into the capsid and the newly generated virus is released by lysis of the host cell 
(Tollefson et al. 1996).  
 
  
1.3 Adenoviral vectors for gene therapy 
 
 The ability of adenoviruses to transduce a broad range of cell types, dividing and non-
dividing and the episomal nature of its dsDNA genome make adenoviruses and its vectors an 
attractive tool for gene therapeutic applications. Moreover, high titres of adenoviral vectors 
can be produced. To re-engineer adenovirus to adenoviral vectors some genes of the 
adenoviral genome must be removed. This removal makes way for the insertion of therapeutic 
transgene expression cassettes. Recombinant adenoviral vectors (rAdV) have been used in 
gene therapeutic trials treating diseases of liver, lung, eye, muscle and brain (Alba et al. 2005, 
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Jager and Ehrhardt 2007). To date, most clinical trials for gene therapy involved adenoviral 
vectors (n=342) (www.wiley.co.uk /genmed/clinical).  
 
 
1.3.1 First generation adenoviral vectors 
 
 The 1st generation of adenoviral vectors lack the E1 and E3 sequences (∆E1/E3) 
[figure 2B] rendering these vectors replication deficient in non-cancer cells due to the 
missing E1A expression, and reduced in transactivation of other early gene clusters for 
example E4. The lack of the immune-modulating E3 proteins does not affect vector 
propagation and experiments in vitro. In vivo, however, 1st generation vectors significantly 
elicited the host cell immune system by de novo viral protein synthesis, causing innate, cell-
mediated and humoral immune responses. Despite the high transduction and transgene 
expression rates, long-term vector genome maintenance was prevented by clearance of 
transduced cells. Furthermore, an efficient re-administration of the vector was difficult due to 
the development of memory cells (Benihoud et al. 1999; Zhang 1999). However, transgene 
expression and persistence of 1st generation AdV can be detected in certain mouse strains for 
several months (Ehrhardt and Kay 2002; Wadsworth et al. 1997). 
 
 
1.3.2 Gene-deleted adenoviral vectors 
 
 The latest development in vector design was the construction of adenoviral vectors 
lacking all early and late viral coding sequences [figure 2C]. These so-called gene-deleted 
adenoviral vectors (GD AdV) only retain the ITRs flanking the vector genome at its termini 
and a packaging signal (Ψ) as the prerequisites for initiation of vector DNA amplification and 
encapsidation (Fisher et al. 1996; Kochanek et al. 1996; Hearing et al. 1987; Gräble and 
Hearing 1990, 1992). The production of GD AdV is realised by co-infection with a helper 
virus providing all wild type viral genes in trans excluding E1 (for more details see the 
chapter on GD AdV production in the section material and methods). The only viral proteins 
that are introduced into the host cell by GD AdV, are the capsid proteins, the TP covalently 
attached to the 5’ termini and DNA-binding proteins pVII and µ (Steward et al. 1993; Russell 
2000). There is no viral de novo gene expression.  
There are some advantages of GD AdV for gene therapy of inherited deseases. Despite their 
improved toxicity profile regarding immune responses, GD AdVs have a large capacity of 
incorporating foreign DNA and transgene sequences. In contrast to 1st generation vectors with 
insert size limitation of 8.2 kb, therapeutic and other advantageous DNA sequences of up to 
  Introduction 
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36 kb can be introduced into the GD AdV genome. For the treatment of Duchenne muscular 
dystrophy for example, this offers the possibility to incorporate the large transgene expression 
cassette of the human dystrophin gene (Matecki et al. 2004; Dudley et al. 2004). Furthermore, 
it is feasible to construct vectors with additional elements leading to vector genome 
persistence by providing DNA-maintaining functions. However, to date it is not clear which 
molecular mechanisms are responsible for the persistence of gene-deleted vector genomes. 
 
Gene deleted adenoviral vector
Adenovirus 5 wild type
-3´ITRITR5´- Ψ ∆E3∆E1
1st generation adenoviral vector
-3´ITRITR5´- Ψ
A
B
C
-3´ITRITR5´- Ψ E1 E2B E2A E3 E4L1 L2 L3 L4 L5
 
 
 
 
 
1.3.2.1 Immune response against gene-deleted adenoviral vectors 
 
 The acute or chronic hepatotoxicity caused by viral protein expression that was 
observed in in vivo experiments using 1st generation vectors, was not detectable after GD 
AdV administration (Kim et al. 2001; Morral et al. 1998; Schiedner et al. 1998; Chuah et al. 
2003). However, the incoming adenoviral capsid proteins elicit an immune response and 
reactivate existing anti-adenoviral capsid memory cells. This can lead to a life-threatening 
anaphylactic shock in a dose dependent manner. Brunetti-Pierri and colleagues showed that 
baboons injected with GD AdV at a dose of 5.6x1012 viral particles (vp)/kg reacted only with 
a moderate immune response, which subsided after 24 h. Upon injection of a higher viral dose 
(1.1x1013 vp/kg), however, the animal suffered from severe toxicity (Brunetti-Pierri 2004). A 
clinical trial aiming at the treatment of ornithine transcarbamylase deficiency with a 2nd 
generation vector resulted in the death of one of the patients enrolled (Raper et al. 2003). This 
adverse event was caused by a fatal systemic inflammatory response against structural 
adenoviral proteins. Therefore, a successful gene replacement gene therapy for inherited 
diseases needs to meet the following objectives: Limited immunogenicity and insertional 
Figure 2: Schematic overview over the viral and vector genomes. A: Adenovirus wild 
type; the early (E1-4) and late (L1-5) genes are indicated. B: first generation vector lacking 
E1 and E3; C: gene-deleted adenoviral vector. Elements shown in red represent deletions. 
The resulting space can be used for the insertion of transgenes and other DNA sequences. 
The single elements depicted are not drawn to scale. 
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mutagenesis, long-term transgene expression and vector genome persistence after one single 
vector administration.  
 
 
1.3.2.2 Long-term persistence of recombinant adenoviral vectors 
 
 Persistence and long-term transgene expression of 1st generation AdV for up to one 
year was shown in rodents (Ehrhardt and Kay 2002; Barr et al. 1995). Also GD AdV persist 
long-term in small and large animal models with negligible induction of the immune system. 
For example, human α-1-antitrypsin was expressed longer than one year in baboons after GD 
AdV administration (Morral et al. 1999). Sustained transgene expression of α-fetoprotein was 
detectable for about two years in baboons and apolipoprotein E (ApoE) expression was even 
maintained life-long (2.5 years) in ApoE-deficient mice (Brunetti-Pierri et al. 2006; Kim et al. 
2001). Moreover, transgene expression was persistent for 413 days in non-human primates 
after administering GD AdV via a minimally invasive liver-directed infusion method 
(Brunetti-Pierri et al. 2007). Phenotopic correction of haemophilia B was achieved in a dog 
model for about two years with GD AdVs (Brunetti-Pierri et al. 2005). Furthermore, Toietta 
et al. reported life-long correction of hyperbilirubinemia in rats with GD AdVs (Toietta et al. 
2005). These examples show that host cells of different organs maintain the vector genome 
and that recombinant AdV genomes can persist long-term within a transduced cell. However, 
the molecular mechanisms involved in episomal persistence of recombinant AdV are 
unknown. 
 
 
1.3.2.3 Previous work on the persistence of recombinant adenoviral vectors 
 
 The in vivo persistence of rAdV is influenced by the DNA sequences enclosed in the 
adenoviral vector genome, the transgene expression cassette and its methylation status 
(Cristiano et al. 1993; Parks et al. 1999; Grave et al. 2000; Brooks et al. 2004; Van Linthout 
2002). Moreover, the persistence is influenced by the vector dosage, the mouse strain or 
experimental animal, the innate immediate immune response as well as cell-mediated and 
humoral immune reactions (Mills et al. 2000; Barr et al. 1995; Schowalter et al 1999; 
Ehrhardt and Kay 2002; Lieber et al. 1997a; Zhang et al. 2001).  
However, anti-viral immune responses are not the primary reason for the progressive loss of 
rAdV genomes, since a similar duration of transgene expression was observed in immuno-
compromised and immuno-competent mice infected with GD AdV or 1st generation AdV 
(Ehrhardt et al. 2003; Barr et al. 1995; Lusky et al. 1998). Ehrhardt et al. (2003) reported that 
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slowly declining transgene expression levels of human blood coagulation factor IX (hFIX) 
were detectable in C57Bl/6 and immuno-compromised C57Bl/6-SCID mice. Furthermore, no 
decreased transgene expression was found in mice that received anti-adenoviral cytotoxic T-
cell lymphocytes (Wadsworth et al. 1997). All these reports suggest that the progressive loss 
of adenoviral vector genomes can only be in part dependent on host immune reactions.  
Cell cycling of transduced host cells was proposed as another possible mechanism accounting 
for the continuous loss of vector genomes over time. In quiescent or slowly proliferating host 
cells vector genome maintenance could be prolonged (Carpenter and Stevens 1996; Wagner 
and Bloom 1997). In fast replicating host cells, on the other hand, loss of vector genomes 
might be accelerated, if there is no intrinsic feature of the vector mediating its persistence. 
This question was addressed by Ehrhardt and co-workers by inducing rapid liver cell 
proliferation in mice after transduction with a GD AdV (Ehrhardt et al. 2003). GD AdV 
genomes were maintained to a much higher degree than a non-viral plasmid-derived control 
vector. From these findings the authors concluded that host cell division alone is not the 
primary cause for declining transgene expression.  
Furthermore, the possibility of rAdV genome integration into the host genome as mechanism 
of persistence was investigated (Harui et al. 1999; Stephen and Kochanek 2007). 1st 
generation AdV integrates at a rate of 10-3 to 10-5 in vitro (Harui et al. 1999). Stephen and 
Kochanek found that the in vivo integration frequency of the preferentially episomal GD 
adenoviral vectors is low in murine liver. Since the murine liver consists of approximately 
1x108 hepatocytes, it is expected that integration occurred only in 10 to 1000 hepatic cells.  
Therefore, it is likely that other mechanisms mediate sustained persistence of GD AdV 
genomes in quiescent as well as in proliferating host cells. 
 
 
1.3.2.4 Potential mechanisms of persistence and molecular conformations of recombinant 
adenoviral vectors 
 
 How is the adenoviral vector genome maintained in the host cell during cell cycling in 
vivo? Currently, there are several potential mechanisms and molecular conformations under 
discussion that also might mutually interact (Jager and Ehrhardt 2007; Ehrhardt et al. 2003). 
(I) Either the adenoviral vector genome replicates episomally or it (II) forms concatemers or 
(III) circularises. The vector DNA may contain areas that possess (IV) centromeric function 
or mediate (V) nuclear retention [figure 3]. 
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Figure 3: Potential mechanisms of persistence and molecular conformations of gene-
deleted adenoviral vector genomes during the cell cycle in vivo. A: Episomal replication; 
B: Concatemer formation; C: Circularisation; D: Nuclear Retention; E: Centromeric function.  
 
In the present study it was analysed whether GD AdV genomes replicate episomally 
and form concatemers or circles.  
(I) Episomal replication of a circular DNA molecule is responsible for persistence of 
Epstein-Barr-Virus in lymphocytes using an origin of replication and Epstein-Barr nuclear 
antigen 1 (EBNA1) (Hammerschmidt and Sugden 2004, Ritzi et al. 2003; Aiyar et al. 1998). 
Furthermore, high amounts of vector DNA after a surgical two-thirds partial hepatectomy 
(Ehrhardt et al. 2003) and the prolonged persistence of GD AdV for up to 2 years in rats, dogs 
and non-human primates (Brunetti-Pierri et al. 2007; Ehrhardt and Kay 2002; McCromack et 
al. 2006), led to the hypothesis that vector DNA replication may contribute to episomal 
persistence. Replication of the GD AdV vector used in the present study might rely on 
activation of putative mammalian origins of replication located within the alphoid repeat 
DNA of this vector [figure 4]. Replication of GD AdV vector genomes would occur 
completely independent of viral E1 and E2 proteins. Moreover, replication of GD AdVs could 
be responsible for keeping up an equilibrium between decrease and increase of vector DNA 
during mitosis. Even a combination of several mechanisms is imaginable. 
(II) Concatemer formation takes place in other gene transfer systems based on 
transfection of linear naked DNA (Chen et al. 2003) or transduction of target cells with 
recombinant adeno-associated viral (AAV) vectors (Miao et al. 1998). Weiden and Ginsberg 
Chromosome 
Centromere 
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have previously shown that deletions in the early region 4 (E4) of the adenoviral genome 
produce DNA head-to-head, tail-to-tail and head-to-tail concatemers (Weiden and Ginsberg 
1994). These large chains of DNA consist of multiple viral genomes connected to each other. 
The connection itself is carried out by double-strand break repair (DSBR) proteins of the host 
cell (Boyer et al. 1999; Stracker et al. 2002). We speculated that concatemeric vector DNA 
could be more persistent during host cell mitosis due to combination and multiplication of 
stabilising effects of one monomer (centromeric region, matrix attachment region, nuclear 
retention signals) within one large multimeric molecule. Additionally, it could be that host 
enzymes leading to degradation of vector DNA do not recognise multimeric vector genomes 
as efficiently as smaller molecules.  
(III) Circular DNA molecules persist within the nucleus of the host. This was shown 
for numerous DNA viruses like members of the Herpesviridae, Hepadnavirus and non-viral 
vectors like pEPI (Roizman and Sears 1996; Ganem 1996; Stehle et al. 2003, Ehrhardt et al. 
2008). Therefore, circularisation seems to favour genome persistence through, apart from 
replication of circular genomes, yet unknown mechanisms. Furthermore, circularisation of 
vector genomes could play an important role for episomally replicating vectors because the 
difficulties associated with replication of linear DNA would be circumvented by a rolling 
circle or theta-replication mode. A rolling circle and theta-replication was already 
demonstrated for Epstein-Barr-Virus and simian virus 40 (Gussander and Adams 1984; 
Pfüller and Hammerschmidt 1996; Li and Kelly 1984). Moreover, Kreppel and Kochanek 
reported circularisation of one of their GD AdVs (Kreppel and Kochanek 2004).  
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Aims of this work 
 
 
Recombinant adenoviral vectors (rAdV) that are administered as gene therapeutic 
vehicles contain a double-stranded DNA genome. The vector genomes are introduced into the 
host cell as linear monomers and persist as episomes. First generation adenoviral vectors lack 
the early genes E1 and E3 (∆E1/E3) whereas gene-deleted adenoviral vectors (GD AdV) lack 
all viral coding sequences. In multiple studies it was demonstrated that rAdV genomes are 
maintained for several months and up to years in small and large animal models resulting in 
long-term phenotopic correction of genetic disease. However, the mechanism of vector 
genome persistence and the molecular status of rAdV DNA are unknown. Therefore, it was 
the goal of the present study to analyse three potential mechanisms of genome persistence and 
molecular conformations of rAdV DNA: Episomal replication, concatemer formation and 
circle formation. These possibilities of genome maintenance have also been discussed for 
members of the Herpesviridae and recombinant adeno-associated virus. 
Within the present study, tropism and stability of transgene expression of GD AdV were 
analysed in vivo. To analyse episomal replication of GD AdV, it was the plan to establish a 
methylase/restriction endonuclease-based system. After transduction of eukaryotic cell lines 
and murine liver, this system was used to investigate the replicative state of GD AdV by 
endonuclease digestion. 
Additionally, we aimed at investigating the possibility of concatemer and circle formation of 
rAdV in vitro by pulsed field gel electrophoresis. Moreover, a polymerase chain reaction 
specific for concatemeric and circular rAdV genome conformations was established analysing 
concatemerisation and circularisation of ∆E1/E3 and GD AdV in quiescent and proliferating 
murine liver. 
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B Material and Methods 
 
 
1. Material 
 
1.1 Plastic ware 
 
All sterile plastic ware was supplied by Peske and Falcon. 
 
1.2 Chemicals and enzymes 
 
All chemicals were obtained from Roth or Sigma, respectively. All enzymes were purchased 
from New England Biolabs, if not stated otherwise. 
 
1.3 Equipment 
 
Bench top centrifuge   Biofuge fresco, Heraeus 
Clinical centrifuge   Rotanta 460, Hettich 
Electroporator    Gene Pulser II, Biorad 
ELISA reader    Sunrise, Tecan 
Luminometer    Microlumat Plus LB 96V, Berthold 
Luciferase live imager  IVIS Imaging System 200 Series, Xenogen 
Light-Cycler    Light Cycler 2.0, Roche 
Light microscope   Axiovert 25, Zeiss 
PCR cycler    T professional basic, Biometra 
Phosphoimager   FLA-3000, Fujifilm 
Pulsed Field Gel Elecrophoresis CHEF-DR III, Biorad 
Rotor for ultracentrifuge  SW 41, Beckman Coulter 
Spectrophotometer   Ultrospec 3000, Pharmacia 
Taqman-Cycler   7500 Fast Real-time PCR System, Applied Biosystems 
Ultracentrifuge   Beckman Coulter LE 80K 
UV cross-linker   UV Stratalinker 1800, Stratagene 
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2. Viruses, viral vectors, oligonucleotides, plasmids and bacteria 
 
2.1 Viruses and viral vectors 
 
Table 1: Overview over viruses and viral vectors used. 
 
          Virus/vector 
            
  Relevant characteristics 
   
           Reference 
            
 Figure 
     
Adenovirus serotype 5 
wild type (Ad5 wt) 
Natural virus occurring in 
the human population 
Garnett et al. 2002       1   
and 2A 
∆E4 mutant virus 
(H5dl1004) 
Ad5-based, deletion in E4 
coding sequence (ORF2-
ORF7) 
Sandler and Ketner 
1989; Weiden and 
Ginsberg 1994  
              
   24A 
Helper virus 
(AdNG163R-2) 
Ad5-based, inverted 
packaging signal Ψ is 
flanked by loxP-sites; 
promotes replication of GD 
AdV 
Palmer and Ng 2003       5 
1st generation vector 
(∆E1/E3) 
Ad5-based, deleted for E1 
and E3 regions; transgene 
hFIX is driven by SV40 
promoter  
Ehrhardt and Kay 2002     2B             
      
Gene-deleted adenoviral 
vector ApoE HCR hAAT 
hFIX (GD AdV) 
Ad5-based, no viral coding 
sequences, transgene hFIX 
is regulated liver-
specifically 
Ehrhardt and Kay 2002       4 
Gene-deleted adenoviral 
vector ApoE HCR hAAT 
luc (GD AdV luc) 
Ad5-based, no viral coding 
sequences, transgene 
luciferase is regulated by 
liver-specific 
promoter/enhancer 
This study      14 
Gene-deleted adenoviral 
vector SV40 luc (GD 
AdV SV40 luc) 
Ad5-based, no viral coding 
sequences, transgene 
luciferase is regulated by 
SV40 promoter 
This study  
 
 
2.2 List of oligonucleotides 
 
Table 2: Overview over the oligonucleotides used in this study. All oligonucleotides were 
obtained from operon. Oligonucleotides were stored as 10 µM stock solution. The working 
concentration was 200 nM, if not stated otherwise. 
 
       Target/Name Orientation                   Sequence 5’ to 3’ Restriction 
recognition 
GAPDH Forward TGC CTC CTG CAC CAC CAA CT  
GAPDH Reverse CGC CTG CTT CAC CAC CTT  
CircleRevHDhFIX436 
Rev436 
Reverse ACG CCA CTT TGA CCC GGA ACG  
CircleForHDhFIX5781 
For-1700 
Forward TCA GGC CAA GCT TAT CGA AAT 
TCC 
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Table 2 continued    
       Target/Name Orientation                   Sequence 5’ to 3’ Restriction 
recognition 
Ad5ITRfw1-24 For/Rev CAT CAT CAA TAA TAT ACC TTA 
TTT 
 
H5dl1004For35585Circ Forward CAC CAG CTC AAT CAG TCA CAG 
TG 
 
U6Rev775 Reverse AGA TCT CGA GCT AGC GGC CTA 
AC 
 
32591Forfibercircle Forward TCA GTC AAG TTT ACT TAA ACG 
GAG 
 
Ad5ForITREnde35836 Forward CTA CGT CAC CCG CCC CGT TCC  
TaqFor Forward TCT GAG GCG GAA AGA ACC A  
TaqRev Reverse AAC AGC CTT GTA TCG TAT ATG 
CAA A 
 
SondeRep  [6-FAM] TTC ACC GAG GGC CTA 
TTT CCC ATG AT [TAMRA] 
 
L3 forward Forward AGA AGC TTA GCA TCC GTT ACT 
CGA GTT GG 
 
L3 reverse Reverse ATA AGC TTG CAT GTT GGT ATG 
CAG GAT GG 
 
L3-specific probe  [6-FAM] CCA CCC GTG TGT ACC 
TGG TGG ACA [TAMRA] 
 
LeberProForSacI Forward AGA GCT C SacI AC TAG TCT GCA GGC 
TCA GAG 
LeberProRevNheI Reverse AGC TAG C NheI AT CGA TAC CGT CGA 
GGC CGC 
PaeR7Rev Reverse TTGCCGTGCAGCTTCACGGTTG  
ForPaeR7Methylase Forward ACGATTGACCGTATTACCCCGG  
RevpIRESpuro2 Reverse CAAAGGGTCGCTACAGACGTTG  
PMTSequenzierung Forward TACGGGCTGAGCCACGAAGAAC  
 
 
2.3 Plasmids 
 
Table 3: Plasmids used for cloning and production of GD AdV. 
 
           Plasmid name 
 
                        Characteristics   Reference              
pGL3 Luciferase expression, SV40 promoter, AmpR Promega 
pGL3 ∆SV40  
   
pGL3 w/o SV40 promoter, MCS w/o XhoI, 
BglII and HindIII sites, AmpR 
 
pIRESpuro2   5.2kb, AmpR Clontech 
pIRESpuro2 PMT  
  
PaeR7 methyl transferase as PCR-amplified 
BamHI fragment, AmpR 
This study 
pCEP-PMT   
 
Based on pCEP4, 10.2 kb, PaeR7 methyl 
transferase, AmpR 
Nelson and 
Kay 1997 
pFTC ApoE HCR hAAT luc
  
   
Based on pAdFTC, ApoE-HCR-hAAT 
promoter/enhancer and luciferase gene as I-
CeuI/PI-SceI fragment, AmpR 
This study 
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Table 3 continued   
           Plasmid name 
 
                        Characteristics   Reference              
pFTC SV40 luc 
  
 
Based on pAdFTC, SV40 promoter drives 
luciferase, cloned as I-CeuI/PI-SceI fragment, 
AmpR 
This study 
pGL3∆SV40 ApoE HCR 
hAAT luc 
 
w/o SV40 promoter, contains liver-specific 
ApoE-HCR-hAAT enhancer/promoter and 
luciferase gene, AmpR 
This study 
pHM5    Shuttle vector, KanR Mizuguchi 
and Kay 1999 
pAdFTC  
  
Ad5 cloning plasmid, AmpR Ehrhardt and 
Kay 2002 
pHM5 SV40 luc 
  
SV40 promoter and luciferase, as SalI/SacI 
fragment from pGL3, KanR 
This study 
pHM5 ApoE HCR hAAT 
luc  
Liver-specific enhancer/promoter and 
luciferase, as SalI/SacI fragment from 
pGL3∆SV40 ApoE HCR hAAT, KanR, 
This study 
pAAV-EF1a-hFIX  human elongation factor 1a [EF1a] gene 
enhancer/promoter-driven human coagulation 
factor IX [hFIX] expression cassette 
Nakai et al. 
2001 
pCRBluntIITopo Cloning of PCR fragments, KanR Invitrogen 
 
 
2.4 Bacteria 
 
Table 4: Bacterial strains. 
 
 E. coli strain 
 
                                   Characteristics Reference 
DH10B F- mcrA Δ(mrr-hsdRMS-mcrBC) φ80lacZΔM15 ΔlacX74 
recA1 endA1 araD139 Δ(ara, leu)7697 galU galK λ- rpsL 
nupG 
Invitrogen 
DH5α endA1 hsdR17(rk-mk+) supE44 thi-1 recA1 gyrA relA1 
Δ(lacZYAargF) U169 (φ80lacZΔM15) 
Hanahan 
1983 
Sure 
 
 
e14– (McrA–) ∆(mcrCB-hsdSMR-mrr)171 endA1 supE44 
thi-1 gyrA96 relA1 lac recB recJ sbcC umuC::Tn5 (KanR) 
uvrC [F' proAB lacIqZ∆M15 Tn10 (TetR)] 
Stratagene 
Stabl-2 F- endA1 glnV44 thi-1 recA1 gyrA96 relA1 Δ(lac-proAB) 
mcrA Δ(mcrBC-hsdRMS-mrr) λ- 
Invitrogen 
 
 
3. Bacterial media, strain cultivation, storage and antibiotics 
 
All bacteria were routinely grown in Luria-Bertani (LB) medium (1% trypton, 0.5% 
yeast extract, 0.5% NaCl). Liquid media were sterilised by autoclaving (121 °C at 1 bar for 20 
min). For solid agar, 1.5% agar were added. If required, media were supplemented with the 
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respective antibiotic. Bacteria on LB-agar were cultivated over night at 37°C, if not stated 
otherwise. Bacteria in liquid culture were cultivated over night at 37°C on a shaking platform.  
 
Table 5: Antibiotics used for selection of prokaryotic and eukaryotic cells. 
 
         Antibiotic 
 
      Abbreviation  Dissolved in Working concentration 
Ampicillin Amp H2O 50 µg/ml 
Kanamycin Kan H2O 20 µg/ml 
Puromycin Puro H2O 575 ng/ml 
Hygromycin Hyg H2O 100 µg/ml 
  
 
4. Molecular genetic methods 
 
4.1 Plasmid Mini-Preparation 
 
3 ml of a bacterial over night culture were spun down at 15.000 x g for 1 min in a 
bench top centrifuge. The supernatant was discarded and the bacterial cell pellet was 
resuspended with 200 µl of resuspension buffer P1 (Qiagen). After addition of 200 µl of lysis 
buffer P2 (Qiagen), the sample was mixed and incubated at RT for 5 min. After addition of 
200 µl of neutralisation buffer P3 (Qiagen), the sample was mixed and centrifuged for 10 min 
at 15.000 x g. The supernatant was transferred to a new Eppendorf tube, and 250 µl of 
phenol:chloroform:isoamylalcohol (PCI, 25:24:1) were added under the extractor hood. The 
sample was centrifuged at 15.000 x g for 2 min and the upper phase was transferred to a new 
Eppendorf tube. Thirty µl of sodium acetate (3 M NaAc, pH 5) and 800 µl of ice cold 100% 
ethanol were added. The solution was mixed and the tube was centrifuged at 15.000 x g for 5 
min. The supernatant was completely removed and the pellet was resuspended in 100 µl H2O. 
 
 
4.2 Determination of the DNA concentration  
 
The concentration of DNA was determined using spectrophotometry. One microlitre 
(µl) of DNA solution was measured in 49 µl dH2O using the Ultrospec 3000 
spectrophotometer (Pharmacia Biotech). The concentration of the DNA was calculated using 
Lambert Beers Law which states concentration of double-stranded DNA in mg/ml = A260 x 
1000 x dilution factor (50), whereby A is the adsorption coefficient of DNA at 260 nm. The 
solution was also measured to determine the absorption at 280 nm for proteins. Only DNA 
samples with a A260/A280 ratio of 1.7-2.0 were used for experiments. 
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4.3 Electro-transformation of bacteria 
  
The DNA was added to micro-centrifuge tubes. For re-transformations, 1 μl of the plasmid 
DNA were used. For newly ligated plasmids, up to 2 µl of the ligation mix were used. DH10B 
electro-competent cells were thawed on ice. Forty μl of competent cells were transferred to 
0.2 cm cuvettes and plasmid DNA was added. Samples were electroporated with a BioRad 
GenePulser® II electroporator using the following conditions: 2.5 kV, 200 Ω, 25 μF. 1 ml of 
LB medium was immediately added after transformation and the suspension was transferred 
to a 1.5 ml Eppi. The transformed bacteria were shaken for 1 h at 37°C and subsequently 
plated on the appropriate solid agar. 
 
 
4.4 Manipulation of plasmid DNA 
 
4.4.1 Restriction digestion of DNA and agarose gel electrophoresis 
 
Plasmid DNA or DNA fragments generated by PCR were digested with 4 units of the 
respective restriction endonuclease in a total volume of 20 µl for analytic digests or 80 µl for 
preparative digests. Digests were performed for at least 1 h at the respective cleaving 
temperature. Cleaved DNA samples were loaded onto 1 % agarose gels containing ethidium 
bromide for visualisation.   
 
 
4.4.2 Isolation of DNA fragments from agarose gels 
 
After running the 1% agarose gel, the respective band of DNA was cut out. Exposure 
of the DNA to UV light was reduced to a minimum to avoid mutations. The cut out gel slices 
were transferred to Eppendorf tubes and the DNA was isolated using a Qiagen gel extraction 
kit according to the manufacturer’s instructions. The DNA fragments were eluted in 30 µl 
dH2O. 
 
 
4.4.3 Dephosphorylation of DNA fragments 
 
Dephosphorylation of the digested vector DNA was performed to prevent self-ligation. 
DNA was dephorphorylated using 1U of calf intestinal phosphatase (CIP) at 37ºC for 1 h. CIP 
was inactivated by incubation at 75 ºC for 10 min. The dephosphorylated DNA was extracted 
with phenol:chloroform:isoamylalcohol and ethanol precipitation. The precipitated DNA was 
re-suspended in 20 μl of dH2O. 
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4.4.4 Ligation of DNA fragments and plasmids 
 
According to the size of the respective fragments/plasmids used in the ligation 
reaction, an excess of insert DNA was added (plasmid:insert 1:4). 400 units of T4 DNA ligase 
were used in an as small as possible reaction volume. Ligation was performed for 1 h at room 
temperature. A control ligation without insert was always included. 
 
 
4.5 DNA-Sequencing and bioinformatic analysis 
 
To control the correctness of cloned DNA fragments and to obtain DNA-sequences for 
the design of oligonucleotides, plasmid and viral vector DNA were sent for sequencing to 
MWG (Martinsried). Obtained sequences were analysed using the basic local alignment 
search tool for nucleic acids (BLASTN). Furthermore, the obtained sequences were analysed 
by sequence alignments to known DNA sequences. Both programmes were provided by the 
National Center for Biotechnology Information (NCBI). The database and the respective 
algorithms are available at http://blast.ncbi.nlm.nih.gov/Blast.cgi.  
 
 
4.6 Isolation of DNA from eukaryotic cells 
 
4.6.1 Isolation of genomic DNA from cell pellets 
 
The cell pellet was resuspended in 200 µl DPBS and vortexed for complete 
resuspension. Two hundred µl lysis buffer (10 mM Tris, 10 mM EDTA, 0.5% SDS) were 
added, supplemented with 30 µl 10% SDS and 15 µl proteinase K (20 µg/ml). The suspension 
was mixed thoroughly and incubated over night at 55°C. The next day, 2 µl RNase A were 
added and the suspension was incubated for 30 min at 37°C. Porteins were removed by 
adding 350 µl of phenol:chloroform:isoamylalcohol. This suspension was mixed and 
subsequently centrifuged for 2 min at high speed in a bench top centrifuge. The supernatant 
was transferred to a fresh tube. Now, the phenol:chloroform:isoamylalcohol extraction was 
repeated as described above. The supernatant was transferred to a fresh tube and DNA was 
precipitated by addition of 50 µl NaAc (pH 5.0, 3 M) and 1 ml ice cold 100% ethanol. The 
DNA was pelleted by centrifugation for 10 min at high speed in a bench top centrifuge. The 
supernatant was removed and the pellet was washed by adding 500 µl of 70% ethanol and 
thorough mixing. This solution was centrifuged for 2 min at high speed in a bench top 
centrifuge. Subsequently, the supernatant was discarded. The pellet was dried and 
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subsequently dissolved in 120 µl of water. For determination of DNA concentration and 
purity a test gel was run and the OD260 was measured. 
 
 
4.6.2 Isolation of low molecular weight DNA from eukaryotic cells 
 
For isolation of low molecular weight (LMW) DNA, particularly viral and vector 
DNA, the DNA was treated according to a modified Hirt-protocol. Tissue culture plates were 
washed once with cold PBS, removed from the plate, and pelleted. Cells were resuspended by 
adding 200 µl lysis buffer/Hirt-solution (10 mM Tris; 10 mM EDTA, pH 7.5; 0.6% SDS). 
One hundred µl of 5 M NaCl were added. The sample was incubated over night at 4°C. After 
centrifugation at 13.000 rpm at 4°C for 40 min, the pellet was discarded and 25 µg of 
proteinase K (34 U/mg of protein) were added to the supernatant and incubated at 37°C for 1 
h. LMW DNA was extracted twice with phenol/chloroform/isoamylalcohol (25:24:1, 
Invitrogen) extraction. The viral DNA was precipitated at –80°C for at least 3 h by adding 
two volumes of 100% ice cold ethanol and 3 M NaAc (pH 5), followed by centrifugation at 
13.000 rpm at 4°C for 1 h. The pellet was washed with 70% ethanol and centrifuged for 5 
min. The DNA was partially dried and the pellet was resuspended in 100 µl of sterile H2O.  
 
 
4.6.3 Isolation of genomic DNA from liver 
 
Two ml lysis buffer (40 mM NaCl, 10 mM Tris pH 7.5, 10 mM EDTA) were filled 
into 50 ml tubes (Falcon) and 300 µl of 10% SDS were added. Approximately 0.1 g of liver 
tissue was used. Small pieces of tissue were immediately transferred to the prepared lysis 
buffer. Ten µl of Proteinase K (20 mg/ml) were added and the samples were incubated at 
55°C for 2 h with permanent gentle shaking. Subsequently, 15 µl RNase A (10 mg/ml) were 
added and the samples were incubated over night at 37°C on a shaking platform. 
On the next day the samples were extracted twice with 500 µl phenol:chloroform: 
isoamylalcohol (25:24:1). After centrifugation at 3000 rpm for 2 min the supernatant was 
transferred to a 15 ml Falcon tube. For precipitation of the DNA, three volumes of ice cold 
100% ethanol were added and the samples were mixed thoroughly. Subsequently, the samples 
were centrifuged at 2000 rpm for 10 min. Afterwards, the supernatant was discarded and the 
DNA-pellet was briefly air-dried. To solve the DNA 500 µl freshly prepared TE buffer (10 
mM Tris pH 7.5, 1 mM EDTA, 10 µg/ml RNase A) were added and the samples were gently 
shaken for 2 h at room temperature. For long-time storage the samples were frozen at -20°C. 
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4.7 Pulsed Field Gel Electrophoresis (PFGE) 
 
Cells were removed from culture plates, pelleted and resuspended in 0.25 ml of 
phosphate-buffered saline (Gibco) which was mixed with 0.25 ml of liquid 2% low-melting-
point Incert Agarose (Biozym). This solution was cast into blocks and, after solidification, 
incubated at 55°C for 24 h in 1% SDS/125 mM EDTA with proteinase K at 5 mg/ml. The 
samples can be stored at 4°C in storage buffer (10 mM Tris, 10 mM EDTA). One half of an 
agarose block was loaded on each line of the gel (Gold Agarose, Biozym) and the pockets of 
the gel were sealed with Incert Agarose (1%). As molecular size marker the MidRange II PFG 
Marker (NEB) was used. All gels were electrophoresed in 0.5 x TBE buffer (890 mM Tris, 
12.5 mM EDTA, 890 mM boric acid) at a ramped pulse frequency of 1-20 sec, at 6 V/cm2 for 
24 h (CHEF-DR III, Biorad). 
 
4.8 Southern blotting 
 
4.8.1 Southern transfer of agarose gels  
 
After fractionating the DNA by gel electrophoresis, the gel was soaked in 200 ml of 0.2 N 
HCl for 30 min. The gel was rinsed several times with deionised water. Then, DNA was 
denatured by soaking in alkaline transfer buffer (1 M NaCl, 0.4 M NaOH). Alkaline transfer 
buffer was used to transfer DNA to charged nylon membranes (Hybond-XL, Amersham). 
Transfer of DNA was for 48 h. After transfer, the membrane was neutalised with 
Neutralization buffer II (1 M NaCl, 0.5 M Tris-HCl (pH 7.2)).  
 
 
 4.8.2 Southern blot hybridisation/Labelling of the probe 
 
The blotted membrane was wetted with 2X SSC and pre-hybridised in 25 ml church 
buffer (7% SDS, 0.5 M NaPhosphate (pH 7.5), 1 mM EDTA) at 65°C for 30 min. The probe 
was marked with radioactive αp32CTP according to the manufacturer’s instructions (Prime-It 
II Random Primer Labeling Kit, Stratagene). Subsequently, the probe was purified and non-
incorporated nucleotides were removed using the nucleotide removal kit (Qiagen). The 
purified probe was eluted in 100 µl of elution buffer. One hundred µl of the radioactively 
labelled probe were added to 25 ml of pre-warmed (65°C) church buffer. The membrane was 
hybridised at 65°C in a roller oven over night. On the next day, the hybridised membrane was 
washed with 50 ml washing buffer 1 (2% SSC / 0.1% SDS) for 5 min at 65°C. Subsequently, 
the first wash was removed and a second wash with another 50 ml of washing buffer 1 was 
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performed for 15 min. Additionally, the membrane was washed two times with washing 
buffer 2 (0.1% SSC / 0.1% SDS) for 15 min. Hybridised membranes were detected on photo 
imager plates (Fujifilm) or normal photo films (Kodak). 
 
 
4.8.3 Probes used for Southern hybridisation 
The adenoviral probe was a PCR product from base pair 1 to 354 of the left arm of the 
adenoviral Ad5 genome. The hFIX specific probe (1.6 kb) was generated by cutting plasmid 
pAAV-EF1a-hFIX (Nakai et al. 2001) with HindIII and EcoRI. 
 
4.8.4 Stripping of hybridised Southern membranes 
 
Stripping of hybridised Southern membranes was performed using 0.4 M NaOH for 30 
min at 42°C. 
 
4.9 Analysis of RNA  
 
4.9.1 Isolation of RNA 
 
For isolation of total RNA from eukaryotic cells, the RNeasy kit (Qiagen) was 
employed according to the manufacturer’s instructions. The concentration of isolated RNA 
was determined using a spectrophotometer (Pharmacia). The integrity of the isolated RNA 
was evaluated by agarose gel elecrophoresis. All work was done on ice. Isolated RNA was 
stored at -80°C. 
 
 
4.9.2 Reverse Transcription of mRNA into cDNA/Analysis of cDNA by PCR  
 
Transcription of mRNA into cDNA was done according to the NEB First Strand 
Synthesis Protocol using 2 µg of purified total RNA. 5 μl of cDNA were directly used for 
PCR. PCR conditions were:   
Denaturation:  94°C 2 min  
Denaturation:  94°C 30 sec  
Annealing:  55°C 30 sec  20 - 25 cycles 
Elongation:  72°C 30 sec 
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4.10 Polymerase chain reactions (PCR) 
 
4.10.1 Standard PCR 
 
Reaction components:  
 
Template DNA   0.1-500 ng 
Oligonucleotide 1 (10 µM)   2 μl 
Oligonucleotide 2 (10 µM)   2 μl 
dNTPs (2 mM)   2 μl 
10 x Taq buffer   5 μl 
Taq polymerase (5 U/μl)   0.5 μl 
H2O     ad 50 μl 
 
Cycling parameters:  
 
Denaturation:   94°C  5 min 
Denaturation:   94°C  30 sec 
Annealing:    xx°C  30 sec  30 - 35 cycles 
Elongation:    72°C  y min 
Final extension:72°C 10 min 
 
x: Annealing temperature is dependent on the Tm (melting temperature) of oligonucleotides. 
y: Elongation is typically 1 min per kb of amplified DNA using Taq polymerase. 
 
 
4.10.2 PCR for concatemer and circular monomer detection 
 
PCRs for GD vector were run with the oligonucleotides Rev436, For-1700 and 
Ad5ITRfw1-24, respectively. PCRs for ∆E4 virus and first generation vectors were run with 
the oligonucleotides H5dl1004For and Rev436. The GD AdV concatemer PCR was run with 
45 cycles at 95°C for 5 min, 95°C for 30 sec, 55°C for 30 sec, 72°C for 2 min. The ∆E4 and 
∆E1/E3 AdV concatemer PCRs were run under the same conditions, however, elongation was 
at 72°C for 1 min. PCRs for linear monomer detection were also run under the same 
conditions, but with an elongation time of 30 sec. Input of Hirt-extracted DNA was 400 ng in 
a total volume of 50 µl.  
 
 
4.10.3 Real-time PCR for detection of XhoI-cleavage/GD AdV-replication 
 
DNA was digested with XhoI or NcoI for 24 h. Two hundred ng of total DNA were 
used in a final volume of 20 µl. XhoI cleavage was detected running a PCR-program with 40 
cycles. Amplification and data collection were at 60 °C for 1 min. As probe was used 
SondeRep (500 nM), forward oligonucleotide was TaqFor (200 nM), reverse oligonucleotide 
was TaqRev (200 nM). Probes and oligonucleotides were designed with primerExpress3.0 
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software (Applied Biosystems) and obtained from Operon, Germany. The Taqman Fast 
Universal PCR Master Mix (Applied Biosystems) was used in corporation with a Taqman 
7500 Fast Real Time PCR System (Applied Biosystems). 
 
 
5. Enzyme activity assays 
 
5.1.1 Luciferase assay in vitro 
 
Cells were routinely grown on 24 well plates and were transfected 48 h before 
luciferase measurement. One hundred µl freshly prepared Passive Lysis Buffer (PBL) were 
added to each well to detach the cells from the plate and for cell lysis. The cell suspension 
was transferred into Eppendorf tubes. For complete cell lysis, the cell suspension was once 
frozen in liquid nitrogen and thawed subsequently at 37°C. The samples were measured in 
white 96 well plates (Nunc). First, 35 µl of Luciferase Assay Reagent II (LAR) were filled 
into each well. 5 µl of the samples (cell-PBL-lysate) were added and mixed thoroughly. 
Firefly luciferase was measured at 492 nm and 25°C for 5 seconds. After the firefly luciferase 
measurement, 35 µl of Stop-and-Glow reagent were added. Having mixed the reagents 
thoroughly, renilla luciferase was detected as an internal transfection control in a second 
measurement. Promoter activity was calculated by dividing the firefly luciferase activity 
through the renilla activity. All reagents were purchased from Promega. 
 
 
5.1.2 Luciferase life imaging 
 
D-Luciferin potassium salt (Xenogen) in DPBS was used. Ten µl/g body weight of 
luciferin were administered intraperitoneally 15 min before imaging. For bioluminescence 
luciferase imaging the Xenogen IVIS Imaging System 200 Software was used. Object height 
(1.5 cm) was adjusted as measuring surface. Luciferase expression was detected by an 
exposure time of 60 seconds. Photographs were taken with a CCD camera at an operating 
temperature of at least – 80°C. 
 
 
5.2 Measurement of alanine aminotransferase (ALT)/Analysis of hepatic injury 
 
For the quantitative determination of ALT in murine serum as signal for liver toxicity, 
the reagents of a kit (Randox) were used according to the manufacturer’s instructions. Fifteen 
µl of murine serum were applied to each reaction. 
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5.3 Enzyme Linked Immunosorbent Assay (ELISA) 
 
Detection of hFIX in murine serum was performed in a sandwich ELISA. 96 well plates 
(Nunc MaxiSorp) were coated with an anti-hFIX antibody (Sigma). The anti-hFIX antibody 
was used in a dilution of 1:2000 in coating buffer (0.1 M NaHCO3, pH 9.4). The plates were 
incubated using 50 µl per well at 4°C over night. For blocking, plates were washed with 200 
µl TBST (10 mM Tris-HCl, 150 mM NaCl, 0.05% Tween 20) per well. After removal of the 
TBST solution, 200 µl dilution buffer (TBST + 5% FBS) per well were added and the plates 
were incubated 1 h at room temperature. The plates were washed twice with TBST. Samples 
were diluted in appropriate relations. For generation of a standard curve, purified hFIX 
(ProSpec-Tany Technogene) was used. Fifty µl per well were loaded and the plates were 
incubated for 2 h at 37°C. The plates were washed twice with TBST. For detection an anti-
hFIX-HRPO antibody (Biozol) was used. The anti-hFIX-HRPO antibody was applied in a 
1:1000 dilution. Fifty µl per well were loaded and the plates were incubated for 2 h at 37°C. 
The plates were washed 4x with TBST. For development 50 µl substrate solution (Sigma Fast 
OPD) per well were used and the plates were incubated for 10 min at room temperature. To 
stop and enhance the reaction, 50 µl of 2 M H2SO4 were added to each well. The samples 
were read at 492 nm in a plate reader (Tecan, Magellan3 software). 
 
 
6. Cell culture 
 
6.1 Cell culture media 
 
Growth Medium: 
Modified eagle medium (MEM, PAA) or Dulbecco’s modified eagle medium 
(DMEM, PAA), supplemented with 10% (v/v) fetal bovine serum (FBS, PAA). For 
liver cell lines, non-essential amino acids (PAA) were added. 
 
Freezing Medium: 
DMEM or MEM supplemented with 10% (v/v) FBS and filter sterilised 
dimethylsulfoxide (DMSO).  
 
Phosphate Buffered Saline (PBS) (PAA): 
137 mM NaCl 
2.6 mM KCl 
10 mM Na2HPO4 
1.8 mM KH2PO4 
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Trypsin-EDTA Solution (PAA) 
0.53 mM tetra-sodium ethylene diamine tetra-acetic acid (EDTA) 
0.05% trypsin 
 
 
6.1.1 Cultivation of eukaryotic cell lines 
 
All cells were grown in a humidified incubator at 37°C and 5% CO2.  
Human embryonic kidney 293 cells (ATCC CRL-1573) and HeLa cells (ATCC CCL-2) were 
grown in MEM supplemented with 10% FBS.  
Huh7, Sk-Hep-1 (ATCC HTB 52) and murine Hepa 1A cells were kept in DMEM containing 
10% FBS and 0.1 mM non-essential amino acids.  
116 cells (Palmer and Ng 2003) were used for production of GD vectors. This cell line carries 
a hygromycin resistance gene, expresses Cre recombinase, and was grown in MEM 
supplemented with 10% FBS and 100 µg/ml hygromycin B.  
W162 cells (ATCC CRL-2783), a Vero cell derivative stably expressing the E4 region of 
Ad5, supports the growth of adenoviral E4 deletion mutants. This cell line was maintained in 
MEM with 2 mM L-glutamine, adjusted to contain 1.5 g/L sodium bicarbonate, 0.1 mM non-
essential amino acids, 1.0 mM sodium pyruvate and 10% FBS.  
293M cells were grown in MEM supplemented with 10% FBS and 100 µg/ml hygromycin for 
selection of PaeR7 methylase expressing cells. 293M cells were generated in the present 
study. 
116M cells were routinely grown with DMEM supplemented with 10% FBS, 100 µg/ml 
hygromycin (PAA) for selection of Cre expression and 575 ng/ml puromycin (PAA) for 
selection of PaeR7 methylase expression. 116M cells were generated in the present study. 
 
 
6.1.2 Establishment of cell cultures from cryostocks 
 
The thawed cell suspension was transferred to a tube containing growth medium. Cells 
were collected by centrifugation at 200 g for 3 min at room temperature. The growth medium 
was removed, the cell pellet was re-suspended with 1 ml of fresh growth medium and 
transferred to cell culture dishes containing the appropriate growth medium. 
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6.1.3 Preparation of permanent cell culture stocks in liquid nitrogen  
 
Cells were grown to at least 50% confluency. Cells were trypsinised and collected by 
centrifugation at 200 g for 3 min at room temperature. The supernatant was removed and the 
cell pellet was re-suspended in 3 ml of freezing medium. 500 µl of the cell suspension were 
aliquoted into cryovials and kept in liquid nitrogen for long-term storage. 
 
6.1.4 Passaging of eukaryotic cell lines 
 
At a concluence of more than 50%, cells were split at a 1:10 ratio. Cells were removed 
from the dish with trypsin-EDTA solution (PAA). Trypsinised cells were immediately 
transferred to new cell culture plates containing the appropriate growth medium. 
 
 
6.1.5 Establishment of stable eukaryotic cell lines 
 
Plasmids were transfected into 116 and 293 cells using Superfect transfection reagent 
according to the manufacturer’s instructions. Transfected cells were incubated with the 
respective antibiotics. After 20 days of incubation under selection pressure, single cell 
colonies were isolated. Cells were further expanded in the respective growth medium. 
 
 
6.2 Gene-deleted adenoviral vector hFIX (GD AdV)  
 
GD AdV hFIX was mainly used for the present study. GD AdV AdFTC-hFIX-lucRNAi 
was based on the parental plasmid pAdFTC (Ehrhardt and Kay 2002) and contains Ad5 5’- 
and 3’- inverted terminal repeats (ITR) and a packaging signal (Ψ). The stuffer DNA of this 
vector consists of the matrix attachment region (MAR) of the murine immunoglobulin κ locus 
and alphoid repeat DNA sequences from human chromosome 17. The alphoid repeat DNA is 
equivalent with a centromeric region and contains potential mammalian origins of replication. 
The human blood coagulation factor IX (hFIX) expression cassette was described previously 
(Miao et al. 2000) and contained two liver specific enhancers - apolipoprotein E (ApoE) 
enhancer and the hepatic control region (HCR) - and a human alpha-1-antitrypsin promoter 
(hAAT-p) controlling expression of the hFIX minigene. Additionally, this GD AdV contained 
an expression cassette encoding small hairpin RNA (shRNA) against firefly luciferase driven 
by human U6 snRNA promoter (hU6-p) [figure 4]. The capsid of this vector is identical to 
that of Ad5 wt. 
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ITR5´- Ψ IgκMAR alphoid repeat DNA ApoE/HCR hAAT-p hFIX minigene ITR -3´
GD AdV hFIX
 
 
 
Figure 4: Schematic representation of the genome of gene-deleted adenoviral vector 
hFIX (GD AdV hFIX). For description of the single elements see text. 
 
 
6.3 Large-scale production and purification of viral vectors and viruses 
 
6.3.1 Pre-amplification steps 
 
The linearised GD AdV DNA construct was transfected into the producer cell line 116 
according to the manufacturer’s instructions (Superfect, Qiagen). Sixteen to 18 h post 
transfection, co-infect with helper virus at an MOI of 5. Cells and supernatant (= passage P0) 
were harvested 48 h post-infection and frozen at −80°C. Now, 3 serial passaging steps (P1 - 
P3) on 6 cm, 10 cm and 15 cm dishes are required for pre-amplification of GD AdV. Usually, 
one third of the freezed-thawed lysate of the previous passage is applied to infect the next 
plate. Co-infection with helper virus was always at an MOI of 5. Lysate was generally 
harvested when complete cytopathic effect was observed. 
 
 
6.3.2 Large-scale production of GD AdV 
  
Large-scale GD AdV production was performed as described earlier (Parks et al. 1996; 
Palmer and Ng 2003; Jager et al. 2008 submitted; figure 5). In brief, 10 confluent 15 cm 
dishes of 116 cells were transferred into 1 litre of MEM (Gibco) supplemented with 10% FBS 
(Sigma) and 100 µg/ml hygromycin B (Invitrogen). For production of methylated GD AdV, 
116M cells growing with 575 ng/ml puromycin were used. Over the next days, the same 
growth medium with all necessary supplementals was added to a final volume of 3 litres (500 
ml on days 2 and 3, 1000 ml on day 4). On day five, 3 litres of 116 cells at 3 to 4x105 cells/ml 
were harvested by centrifugation (8 min at 1500 rpm in a clinical centrifuge), resuspended in 
120 ml volume medium and co-infected with 100% of the crude lysate from the 15 cm dish of 
serial passaging step 3 and AdNG163R-2 helper virus (Palmer and Ng 2003) at an MOI of 1 
PFU/cell. In an alternative simplified protocol, purified GD AdV instead of crude lysate was 
used as inoculum at an MOI of 100 for co-infection of 3 litres of 116 cells.Virus adsorption 
was performed at 37°C on a magnetic stir plate for 2 h, after which medium (MEM 
supplemented with 5% FBS, Sigma) was added to a final volume of 2 litres. Co-infected cells 
were harvested 48 h later for lysis via centrifugation for 10 min at 1500 rpm in a clinical 
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centrifuge and were re-suspended in a total volume of 30 ml PBS. Subsequently, GD AdV 
virions were purified. 
 
ITR ITR
5 -´ -3´
∆E3
loxP loxPΨ 
early and late genes
ITR
5 -´
Ψ
ITR
-3´
„stuffer“ DNA Transgene
∆E1
 
 
Figure 5: Large-scale production of GD AdV. The helper virus provides all necessary 
genes for GD AdV production in trans. Helper virus genomes are not efficiently packaged 
due to excision of their packaging signal Ψ in Cre-expressing 116 cells. This method results 
in high titres of GD AdV. In the upper part of the figure, all relevant characteristics of the 
helper virus and the GD AdV are indicated. 
 
 
6.3.3 Large-scale production of Ad5 wt, ∆E4 mutants and 1st generation vector 
 
Ad5 ∆E4 mutants (H5dl1004 lacking nucleotides 2845 to 981 of E4) were amplified in 
W162 trans-complementing cells and Ad5 wild type was amplified in adherent 293 or 293M 
cells. Amplification of the E1 and E3 deleted recombinant 1st generation adenovirus (∆E1/E3 
AdV) was performed in 293 cells. All of these viruses/vectors were produced on 15-30 
confluent 15 cm cell culture plates. Viral particles were purified using CsCl density 
centrifugation (see also 6.3.5). 
 
 
6.3.4 Purification of adenoviruses and adenoviral vectors 
 
Cells and supernatant of infected dishes were collected in conic 500 ml bottles. Cells 
containing the virus were spun down for 8 min at 200 x g. Supernatant was removed and the 
cell pellet was resuspended in 14-28 ml DPBS. This suspension can be stored at -80°C. To 
 
GD AdV packaged Helper virus not packaged 
Helper virus AdNG163R-2 GD AdV 
Cre-loxP recombination 
116 Cre-expressing cells 
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release the virus from the cells, the suspension was four times freezed in liquid nitrogen and 
thawed in a 37°C waterbath. The lysate was spun down for 8 min at 200 x g and the 
supernatant containing the virus was collected. 
For purification of adenovirus preparations, the suspension obtained above was loaded 
onto one step and one continuous gradient. The step gradient was established by pipetting 
CsCl solutions with different densities in the following order: 
 
0.5 ml   1.5 g/cm3 CsCl 
3 ml   1.35 g/cm3 CsCl 
3.5 ml   1.25 g/cm3 CsCl 
5 ml   virus/vector 
 
This step gradient was spun for 1.5 h at 35000 rpm (226000 x g)/ 12°C in an ultracentrifuge. 
The lower bluish band containing the virus was collected and mixed with 1.35 g/cm3 CsCl 
(final volume 12 ml). This continuous gradient was spun for at least 20 h at 35000 rpm 
(226000 x g)/ 12°C. The virus band was collected in an as little volume as possible. The 
purified virus was dialysed over night at 4°C in 2 l dialysis solution (10 mM Tris (pH 7.5, 
10% Glycerol, 1 mM MgCl2) at very low stir speed and aliquotted.  
 
 
6.4 Adenovirus DNA analysis 
 
Fifty µl CsCl-purified virus were incubated in 150 µl lysis buffer (10 mM Tris, 10 mM 
EDTA, 0,5% SDS) supplemented with 10 µl proteinase K (Qiagen, 600 mAU/ml = 20 mg/ml) 
for 2 h at 55°C. Subsequently, samples were purified with phenol:chloroform:isoamylalcohol. 
Samples were centrifuged 2 min at full speed in a bench top centrifuge and upper phase was 
transferred to a new tube. DNA was precipitated with ice cold 100% ethanol for 20 min at -
80°C and centrifugation at full speed and 4°C for 10 min. Precipitated DNA was resuspended 
in 50 µl water. For DNA analysis, 15 µl DNA were digested with restriction endonuclease for 
1.5 h. 
 
 
6.5 Titering of adenoviral vector preparations 
 
6.5.1 Determination of the physical titre 
 
Viral DNA was released from virions obtained from CsCl gradients in TE buffer (10 
mM Tris, 10 mM EDTA) with 0.1% SDS. The A260 was measured to determine the viral titre. 
By the well-characterized absorption of pure adenovi rus at 260 nm (Maizel et al. 1968), an 
OD260 of 0.01 corresponds to a viral particle concentration of 1.1 x 109 VP/ml based on a 36 
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kb size of the wild type particle genome. Thus, total vi ral particles for GD AdV and other 
adenovi ruses were calculated as follows: VP/ml x (OD260 x dilution factor x 36 kb)/(size of 
the vector [kb] x 9.09 x 10–13); where 9.09 x 10–13 is the extinction coefficient for wild-type 
adenovi rus.                  
475 µl of measurement buffer (0.1 M TE, 10 mM EDTA, 0.1% SDS) were added to a 25 µl 
aliquot of the CsCl purified virus. Suspensions were vigorously shaken at 1200 rpm for 15 
min in a table top shaker. Subsequently, samples were briefly centrifuged and subjected to 
OD260nm measurement. Fifty µl of each of 5 aliquots were used for determination. 
 
 
6.5.2 Determination of the infectious titre by Southern blot 
 
To control that similar amounts of ∆E4 and GD AdV genomes were administered, 293 
cells were infected with either virus at OD260 MOIs of 1, 11 and 33. Cells were harvested after 
4 h of incubation with trypsin. Thirty µg of total DNA were analysed on a Southern blotted 
gel. The intensity of the respective band indicates the relative infectious titres. We found 
that ∆E4 and GD AdV show similar titres at the respective MOI [Appendix figure 3]. 
 
 
6.5.3 Determination of the infectious titre by quantitative real-time PCR 
 
Moreover, the number of total genomes and infectious genomes were determined by 
quantitative real-time PCR (qPCR) employing the oligonucleotides Rev436 and Ad5ITRfw1-
24. For determination of total particles, 10 vp/cell were directly administered to pelleted 293 
cells before starting Hirt extraction. Subsequently, total particles were determined analyzing 
200 fg of Hirt-extracted DNA in a total volume of 20 µl. Infectious particles were determined 
analyzing 200 fg of Hirt-extracted DNA of infected (10 vp/cell) 293 cells in a total volume of 
20 µl. These infected 293 cells were harvested with trypsin after 4 h of incubation to remove 
unabsorbed virions. The LightCycler FastStart DNAMasterPlus SYBR Green I (Roche) 
detected the PCR-products. The programme of the LightCycler (Applied Biosystems) was set 
as follows: Pre-incubation at 95°C for 10 min, amplification in 45 cycles at 95°C for 10 sec, 
55°C for 5 sec, 72°C for 30 sec. All MOI indicated in the present study relate to titre 
determinations by OD260 measurements [Appendix figure 2].  
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6.5.4 Determination of the helper virus contamination of GD AdV preparations 
 
The determination of the helper virus conatamination was performed using purified 
adenoviral DNA. To purify adenoviral DNA from CsCl solutions, three independent 
adenoviral preparations, each 20 µl, were incubated with 400 µl of proteinase K-SDS solution 
(proteinase K [0.5 mg/ml], 10 mM Tris-HCl [pH 7.5], 0.5% sodium dodecyl sulfate [SDS], 10 
mM EDTA [pH 8]) for 3 h at 37°C. DNA was then precipitated by addition of 1/10 volume of 
3 M sodium acetate (pH 5.2) and a 2.5 vol of 95% ethanol, rinsed with 70% ethanol, dried, 
and resuspended in 25 µl of water. Preparations of GD AdV were evaluated in three different 
dilutions per assay: 10–3 to 10–5. In a total volume of 20 µl per reaction, 5 µl of the template 
DNA was added. 
Quantitative real-time PCR for helper virus contamination was carried out by the Taqman 
7500 Fast Real Time PCR System (Applied Biosystems) amplifying a 235 bp area of the 
adenoviral late gene 3 (L3). Utilizing the oligonucleotides L3 forward (400 nM) and L3 
reverse (400 nM) together with an L3 specific probe (300 nm) (Ella Biotech) the PCR was run 
with the following programme: AmpErase UNG reaction at 50°C for 2 min, pre-
incubation/activation at 95°C for 10 min, amplification and data collection in 40 cycles at 
95°C for 15 sec and 60°C for 1 min. Universal Fast PCR Master Mix (Applied Biosystems) 
was used for Taqman qPCR. Oligonucleotides, probe and protocol parameters were chosen 
according to Puntel et al. 2006.  
The contamination of GD adenoviral vector with helper virus lays at 0.09% compared to the 
number of total particles [Appendix figure 2]. This amount is well in the range reported by 
others (Puntel et al. 2007). 
 
 
7. Transduction of cell lines 
 
Cell lines were seeded 24 h before transduction at 70 to 80% confluency. At the day of 
transduction, CsCl-purified virions were directly applied to the culture medium at an 
appropriate MOI. Determination of the MOI generally relied on physical (OD260) titres. 
 
 
8. Animal studies  
 
All mice (C57Bl/6 and Balb/c) were kept and treated according to the regulations of 
the Government of Upper Bavaria. All mice were injected via the tail with a total volume of 
200 µl containing 7.5x109 or 1x1010 transducing particles diluted in Dulbecco´s phosphate 
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buffered saline (Gibco), respectively.  
Rapid cell cycling of murine liver cells was induced by intraperitoneal administration of 50 µl 
carbon tetrachloride (CCl4, Sigma) solution (1:1 dilution in mineral oil, Sigma). 
For hydrodynamic plasmid delivery to murine liver, animals were injected via the tail vein 
with 20 µg of plasmid DNA in a total volume of 2 ml PBS within 5 to 8 seconds (Liu et al. 
1999). 
 
 
8.1 Transduction of C57Bl/6 mice with GD AdV ApoE HCR hAAT hFIX  
 
Mouse 1 received GD AdV, was CCl4-treated and sacrificed in week seven post 
infection. Mice 2 and 3 received GD AdV and murine livers were isolated in week five. Mice 
4 and 5 received GD vector, were CCl4-treated and were sacrificed in week nine. Mouse 
number six was infected with GD vector and killed in week nine. Mice 7 and 8 received GD 
AdV and CCl4 and were sacrificed in week nine. Mice 9 and 10 represent the negative control 
for this experiment, were not infected with GD AdV and were killed in week nine. Mouse 10 
was CCl4-treated. For the analysis of the replicative state of GD AdV, the mice were grouped 
as follows: group 1 (GD AdV and CCl4-treated) contains mice 1, 4 and 5. Group 2 (GD AdV-
transduced) consists of mice 2, 3, 7 and 8. Group 3 consists of the untransduced mice 9 and 
10. 
 
 
9. The model transgene human blood coagulation factor IX 
 
Since Ad5-derived rAdV mainly turn to the liver when injected into animals, the 
disease model of this survey is haemophila B. In patients affected by haemophilia B, the 
human blood coagulation factor IX (hFIX) is not expressed or not functional. In healthy 
individuals, hFIX is produced by hepatocytes. Therefore, rAdV carrying an hFIX transgene 
can be effectively used to transfer a functional hFIX gene to the natural site of hFIX 
production. Once expressed in hepatocytes, hFIX can be incorporated in the blood clotting 
cascade, if necessary. 
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C Results 
 
 
1.1 Analysis of tropism and persistence of recombinant adenoviral vectors (rAdV) in vivo 
 
1.1.1 Generation of a luciferase-expressing gene-deleted adenoviral vector (GD AdV) 
 
First, the features of rAdV in vivo were analysed. Therefore, a new GD AdV was constructed 
and produced, to visualise the tropism of and to investigate the duration of transgene 
expression from GD AdV in mice. This GD AdV contains the same stuffer DNA and 
promoter sequences as GD AdV hFIX [figure 4] but expresses firefly luciferase instead of 
hFIX. To construct the production plasmid for the GD AdV expressing luciferase, the liver-
specific promoter and enhancer region (ApoE HCR hAAT; 1.3 kb) was PCR-amplified using 
pBS ApoE HCR hAAT hFIX (Miao et al. 2000) as template. This fragment was cloned into 
an upstream position of the luciferase gene of the plasmid pGL3 basic by SacI/NheI ligation 
resulting in pGL3 ApoE HCR hAAT luc [Appendix figure 5]. The whole enhancer-
promoter-luciferase-polyA DNA fragment (3.2 kb) was then cloned by the restiction enzymes 
SacI/SalI into the pHM5 shuttle plasmid that was named pHM5 ApoE HCR hAAT luc 
[Appendix figure 6]. By PI-SceI and I-CeuI restriction enzyme digest the liver-specific 
luciferase construct was cloned into pAdFTC (Ehrhardt and Kay 2002), resulting in pAdFTC 
ApoE HCR hAAT luc [figure 6].  
 
 
ITR5´- Ψ IgκMAR alphoid repeat DNA HCR ITR -3´MCS
AmpR
NotI NotI
hAAT HCR ApoELuciferaseAAA
I-CeuI PI-SceI
 
 
 
 
 
Figure 6: pAdFTC ApoE HCR hAAT luc. This plasmid was used for the production of GD 
AdV liver-specifically expressing luciferase. The plasmid carries an ampicillin resistance 
gene. Relevant recognition sites for endonucleases are indicated. 
 
This plasmid was characterised by DNA-sequencing and restriction analyses and was tested 
for luciferase functionality in vitro (data not shown). Luciferase expression was liver-specific 
(high expression in Sk-Hep and Huh7 cells), but was inhibited in non-hepatic 293 and HeLa 
cells (data not shown). Using this plasmid pAdFTC ApoE HCR hAAT luc, GD luciferase 
expressing vector particles (GD AdV luc) were produced. Using these GD AdV particles, 
pAdFTC ApoE HCR hAAT luc 
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luciferase functionality in the GD AdV context was confirmed in cell culture by luciferase 
assays (data not shown). Luciferase expression was liver-specific (high expression in Sk-Hep 
and Huh7 cells), but was inhibited in non-hepatic 293 and HeLa cells (data not shown).                
 
 
1.1.2 Investigation of tropism, transduction efficacy, transgene expression and persistence 
of recombinant AdV employing luciferase life-imaging 
 
Balb/c mice were transduced to test the liver transduction efficacy and the transgene 
expression of rAdV. GD AdV luc and a 1st generation vector expressing luciferase driven by 
an SV40 promoter (1st gen. luc) were administered via tail vein injection at a dose of 1x1010. 
A hydrodynamic plasmid injection with 20 µg of pGL3 SV40 luc was performed in a control 
mouse.  
One week after vector administration, high levels of luciferase (up to 1.2 x 107 light units, 
LU) were detected in the liver of the mouse receiving GD AdV luc and 1st gen. Luc, 
respectively [figure 7A]. Expression levels from pGL3 were relatively low (2 x 106 LU). 
Seven weeks p.i., luc expression from GD AdV luc was high (up to 9.8 x 105 LU) throughout 
the liver indicating persistence of GD AdV genomes [figure 7B]. Sixteen weeks p.i, transgene 
expression from GD AdV luc was hardly detectable suggesting either vector genome loss, 
transgene promoter silencing or induction of vector specific immune response in Balb/c mice 
[figure 7C]. Luciferase expression from pGL3 SV40 luc and 1st gen. luc dropped to 
undetectable levels two and three weeks p.i., respectively (data not shown). Taken together, 
the in vivo experiment using rAdV showed that rAdV particles transduce the liver and that the 
GD AdV genomes persist within the organ for several months. These findings are in 
concordance with work previously published (Ehrhardt and Kay 2002, McCormack et al. 
2006). In the following it was investigated how persistence of rAdV might be mediated.  
 
 
1.2 Do gene-deleted adenoviral vectors (GD AdV) replicate? 
 
GD AdV genome replication could explain vector persistence, since replication of 
vector genomes would increase the amount of GD AdV DNA in transduced host cells. The 
GD AdV used in the present study contains putative mammalian origins of replication within 
its alphoid repeat DNA [figure 4]. The question whether GD AdV replicate episomally was 
addressed by a methylase/restriction endonuclease-based system.  
The PaeR7 methylase derived from Pseudomonas aeruginosa transfers methyl moieties to the 
N6-position of the adenine base of its recognition site. Since mammalian cells do not possess
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Figure 7: In vivo luciferase imaging of Balb/c mice dosed with different adenoviral 
vectors. A time course is shown [1 - 16 weeks post injection (p.i.)]. A: Luciferase expression 
one week post injection of different vectors: from left to right: control mouse (injection of 
PBS), pGL3 (hydrodynamic tail vein injection of 2 ml PBS containing 20 µg plasmid pGL3), 
mouse 3 received 1x1010 viral particles of a first generation adenoviral vector (1st gen. luc) 
and mouse 4 was transduced with 1x1010 GD AdV luc particles. All mice received a total 
volume of 200 µl, if not stated otherwise. B: Seven weeks p.i. only the mouse transduced with 
GD AdV luc shows luciferase expression within the whole liver. C: Sixteen weeks p.i., 
luciferase expression from the mouse receiving GD AdV luc is hardly detectable. 
Control GD AdV luc 
7 weeks p.i. 
GD AdV luc 
16 weeks p.i. 
Control pGL3 1st gen. luc GD AdV luc 
One week p.i. 
A 
B C 
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methylases that target adenine bases, the procaryotic PaeR7 methylase uniquely marks the 
DNA. The XhoI endonuclease is an isoschizomer of the corresponding PaeR7 endonuclease 
and was used to test the methylation status of DNA. Only unmethylated DNA is cleaved 
whereas methylated DNA is not. To analyse the methylation/replication status of GD AdV, 
vector genomes were specifically methylated. The only way to remove the specific 
methylation from originally methylated GD AdV is by de novo viral genome synthesis. Thus, 
GD AdV genomes that have replicated, can be cleaved by XhoI whereas the originally 
methylated input GD AdV DNA stays methylated and can not be cleaved [figure 8]. To set 
up this system, cell lines that stably express the PaeR7 methylase were generated. Producing 
GD AdV and Ad5 wt virus in these cell lines, results in specific methylation of PaeR7/XhoI 
recognition sites. 
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Figure 8: The methylase/restriction endonuclease-based system. The addition of a methyl 
group to the N6-position of the adenine base of XhoI sites renders the DNA XhoI-uncleavable. 
Replication restores XhoI cleavage by loss of methylation. XhoI is an isoschizomer of the 
respective PaeR7 methylase. 
 
 
1.3 Establishment of the methylase/restriction endonuclease-based system 
 
1.3.1 Construction of the PaeR7 methyl transferase expression plasmid pIRESpuro2 PMT  
 
The plasmid pCEP-PMT (Nelson and Kay 1997) was used to excise the PaeR7 
methyl-transferase (PMT) gene (1.9 kb) with BamHI. This fragment was cloned into the 
pIRESpuro2 plasmid via BamHI ligation, resulting in pIRESpuro2 PMT. The expression 
cassette of pIRESpuro2 PMT consists of cytomegalovirus promoter, the PMT gene, a 
synthetic intron, an internal ribosomal enty site and the puromycin resistence gene followed 
by a polyA signal [figure 9]. The correct orientation of the PMT insert was verified and the 
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plasmid pIRESpuro2 PMT was further characterised by restriction analyses, PCR and DNA-
sequencing (data not shown).  
 
 
 
 
Figure 9: pIRESpuro2 PMT. Expression plasmid used for cloning of PaeR7 methyl 
transferase and generation of stably methylase expressing cells lines. Note the bicistronic 
expression of the PMT and puromycin resistance gene. CMV IE: Cytomegalovirus immediate 
early, AmpR = ampicillin resistance gene, polyA = polyA signal, bp = base pairs.        
 
 
1.3.2 Generation of stable cell lines for PaeR7 methyl transferase expression 
 
To define an appropriate puromycin concentration for the establishment of stable 116 
cell lines expressing PMT, a dose escalating study was performed in 116 cells [figure 10A]. 
116 cells were used because production and packaging of GD AdV is optimised in these cells 
(Palmer and Ng 2003). A useful puromycin concentration was 575 ng/ml. pIRESpuro2 PMT 
was then transfected into (hygromycin resistant, Cre recombinase expressing) 116 cells and 
after 20 days of puromycin selection, cell clones were isolated and further expanded [figure 
10B]. These new cell lines expressing PaeR7 methyl transferase were named 116M.  Several 
116M cell clones were analysed for PMT expression by isolating total RNA and reverse 
transcription PCR (RT-PCR) of PaeR7 methylase mRNA into cDNA to detect specific 
transcripts. All stable cell clones analysed expressed PMT [figure 11].  
Furthermore, to amplify also methylated Ad5 wt, 293 cells were transfected with pCEP-PMT 
and incubated for 20 days under hygromycin selection. Single colonies were picked and 
further expanded. These methylase expressing cells were termed 293M cells. PMT expression 
M
C
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in 293M cells was confirmed by RT-PCR [figure 12]. Morphology and adherence of 116M 
and 293M cells were similar to original 293 and 116 cells. However, the doubling time of 
both methyl transferase expressing cell lines, however, was slightly longer (23 h) (data not 
shown). 
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Figure 10: Establishment of methylase expressing cell lines. A: Determination of a useful 
puromycin concentration for selection of 116 cells. B: Selection of single cell colonies of 
methylase expressing cell lines. Methylene blue stained cell colonies are shown after 20 days 
of incubation under puromycin selection pressure. Removed colonies selected for further 
expansion are marked by circles. 
 
B 
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Figure 11: Reverse transcription PCR to evaluate PaeR7 methyl transferase expression 
in 116M cells. Two µg of total RNA were used for transcription into cDNA. Five µl of cDNA 
of three different cell clones were analysed (X, Y, Z). Samples were run on a 1% agarose gel. 
A: A PCR product of 900 bp indicates spliced PMT transcripts, a PCR product of 1200 bp 
indicates unspliced (PMT + puromycin mRNA) transcripts. The control (C) is derived from 
plasmid DNA pIRESpuro2 PMT. B: GAPDH control PCR from the same samples as above. 
A band of 350 bp represents GAPDH transcripts. Control (1200 bp) as above. (+) indicates 
addition of reverse transcriptase, (-) w/o reverse transcriptase. (M) = molecular size marker 
[figure Appendix 1]. 
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Figure 12: Reverse transcription PCR to evaluate PaeR7 methyl transferase expression 
in 293M cells. Two µg of total RNA were used for transcription into cDNA. Five µl of cDNA 
of four different cell clones were analysed (A, B, C, D). Samples were run on a 1% agarose 
gel. A: A PCR product of 430 bp indicates PMT transcripts. The control (C) is derived from 
DNA of pCEP PMT. B: GAPDH control reaction from the same samples as above. A band of 
350 bp represents GAPDH transcripts. A band at 430 bp is amplified from pCEP PMT as 
relation. (+) indicates addition of reverse transcriptase, (-) w/o reverse transcriptase. (M) = 
molecular size marker. 
 
 
1.3.3 Evaluation of PMT-functionality in 116M and 293M cells 
 
To evaluate methyl transferase function in 116M and 293M cells, Ad5 wt and GD 
AdV hFIX were produced in these cell lines. As control, the Ad5 wt virus and the GD AdV 
were produced in original 116 and 293 cells. After CsCl purification, virions were 
disintegrated and purified adenoviral and GD AdV genomes were analysed by XhoI 
restriction enzyme digest [figure 13A and 13B]. Ad5 wt and GD AdV DNA produced in 
PMT-expressing cells were resistant to XhoI cleavage, indicating methylation of the 
respective XhoI recognition sites. However, PaeR7 methylation had no effect on digestion of 
Ad5 wt DNA with EcoRI [figure 13B]. In conclusion, the 116M and 293M cells lines express 
significant amounts of functional PaeR7 methyl transferase and retain their potential to 
amplify high titres of wild type virus or GD AdV, respectively (data not shown).  
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Figure 13: Analysis of XhoI sites in Ad5 wt and GD AdV genomes. A: Restriction maps 
for XhoI recognition sites of Ad5 wt (upper panel) and GD AdV hFIX genomes (lower panel). 
B: Methylated adenoviral genomes are insensitive to XhoI digestion. To analyse whether the 
site specific methylation is effective and renders the adenoviral genome insensitive to XhoI, 
un-methylated and methylated CsCl-purified adenoviral genomes were compared on a 1% 
agarose gel. XhoI digest of un-methylated (1) and methylated Ad5 wt (3), EcoRI digest of un-
methylated (2) and methylated (4) Ad5 wt. Undigested controls of un-methylated (5) and 
methylated Ad5 wt DNA (6). XhoI digest of methylated (7) and un-methylated GD AdV 
DNA (8). Uncleaved Ad5 wt and GD AdV DNA run at approx. 35 kb or 28 kb, respectively. 
An additional band at 6 kb indicates XhoI cleavage of GD AdV DNA (8). XhoI or EcoRI 
cleavage of Ad5 wt DNA results in characteristic banding patterns. (M) = molecular size 
marker. 
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1.3.4 PMT-methylation is removed by replication 
 
Next, it was tested whether methylation of adenine residues within XhoI recognition sites can 
be removed by replication. 293 cells and the liver-derived cell lines Huh7, Sk-Hep and Hepa 
1A were infected with methylated Ad5 wt at MOIs of 10 to 3000. 293 cells were transduced 
with methylated GD AdV at an MOI of 1000 and co-infected with helper virus at an MOI of 
10 to promote replication of GD AdV genomes. After an incubation time of 48 to 96 h, low 
molecular weight DNA was extracted from cells and subjected to XhoI digestion. It was found 
that formerly methylated and uncleavable DNA [cf. figure 13] can be cleaved after 
replication [figure 14].  
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Figure 14: XhoI-specific methylation can be removed by replication. A: Replicative status 
of methylated Ad5 wt after infection of mammalian cells. Various cell lines were infected 
with methylated Ad5 wt and incubated for 48 h, if not stated otherwise. DNA was isolated via 
Hirt protocol, digested with XhoI and run on a 1% agarose gel. Sk-Hep cells infected with 
methylated Ad5 wt at an MOI of 100 (1), Sk-Hep cells infected with methylated Ad5 wt at an 
MOI of 100 for 96 h (2), Sk-Hep cells infected with methylated Ad5 wt at on MOI of 3000 
(3), 293 cells infected at MOI 10 (4), Huh7 cells infected at MOI 10 (5), murine Hepa 1A 
cells at MOI 10 (6). 293 cells infected with un-methylated Ad5 wt at MOI 10 (7), CsCl-
purified methylated Ad5 wt (8). Replication and cleavage of Ad5 wt DNA by XhoI are 
indicated by a characteristic banding pattern. (M) = molecular size marker. B: XhoI 
methylation can be removed from methylated GD AdVs by replication. CsCl-purified 
methylated GD AdV genomes digested with XhoI (1). 293 cells were transduced with 
methylated GD AdV at MOI 1000 + helper virus at MOI 10 (2). 72 h post infection DNA was 
isolated via Hirt protocol, digested with XhoI, run on a 1% agarose gel, Southern-transferred 
and hybridised with hFIX and ITR/Ψ probes. Uncleaved Ad5 wt and GD AdV DNA run at 
approx. 35 kb or 28 kb, respectively. An additional band at 6 kb indicates XhoI cleavage of 
GD AdV DNA. 
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In Sk-Hep cells a high MOI (3000) of Ad5 wt had to be transduced to detect replication. At 
low MOI (100) Ad5 wt does not replicate in Sk-Hep cells. Since murine Hepa 1A cells are not 
permissive for human Ad5 wt virus, Hepa 1A cells are an additional control and no 
replication/removal of methylation was seen. Helper-virus-driven replication of GD AdV 
genomes and loss of methylation were shown by Southern blotting, using hFIX and ITR/Ψ-
specific probes [figure 14B]. Thus, de novo genome synthesis of Ad5 wt and GD AdV leads 
to removal of methylation. This removal can be detected by XhoI digestion.  
 
 
1.4 The replicative state of GD AdV genomes in vitro  
 
Next, the replicative state of GD AdV genomes was analysed in cell culture. 
Numerous cell lines (293, Huh7, Sk-Hep and Hepa 1A) were transduced with methylated GD 
AdV at an MOI of 100 to 3000, respectively. Transduced cells were harvested 48 to 96 h post 
infection (p.i.) and low molecular weight DNA was extracted by Hirt protocol. Five µg of 
purified low molecular weight DNA were analysed by XhoI digestion and subsequent 
Southern blotting using hFIX- and ITR/Ψ-specific probes. As shown by detection of full 
length GD AdV genomes after XhoI cleavage, the GD AdV DNA remained methylated and 
did not replicate. This result was independent of the cell type and the amount of vector 
genomes per cell used (MOIs up to 3000) [figure 15]. Purified DNA of disintegrated virions 
from CsCl-purified particles was used as a control in this experiment. Only the unmethylated 
DNA was cleaved by XhoI. 
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Figure 15: Methylated GD AdV DNA does not replicate after infection of mammalian 
cells in vitro. Cells were transduced with methylated GD AdV and incubated for 48 h, if not 
stated otherwise. DNA of samples was Hirt-extracted, XhoI-digested and subjected to 
Southern protocol with hybridising probes detecting hFIX and ITR/Ψ. Sk-Hep cells 
transduced at MOI 2000 for 96 h (1), Sk-Hep cells transduced at MOI 3000 (2), 293 cells 
transduced at MOI 2000 (3), 293 cells transduced at MOI 100 (4), Huh7 cells transduced at 
MOI 2000 (5), Hepa 1A cells transduced at MOI 2000 (6). CsCl-purified methylated GD AdV 
(7), CsCl-purified, un-methylated GD AdV (8). All samples were equally treated with XhoI. 
GD AdV genomes running at 28 kb represent full length DNA. A band at 6 kb indicates 
cleavage by XhoI. 
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1.5. The replicative state of GD AdV genomes in vivo 
 
To analyse the replicative state of GD AdV in murine liver C57Bl/6 mice were chosen 
because of known long-term transgene expression and genome persistence in this mouse 
strain (Ehrhardt and Kay 2002; Belalcazar et al. 2003). C57Bl/6 mice (n=7) were injected via 
the tail vein with 7.5x109 viral particles of methylated GD AdV hFIX. Two control mice were 
mock-infected and received PBS without viral particles. Moreover, to analyse the replicative 
state of GD AdV in proliferating liver tissue three mice were treated intraperitoneally with 
carbon tetrachloride (CCl4). CCl4 is a liver-toxic substance and leads to death of affected 
hepatocytes by necrosis (Weber et al. 2003). As a result, the volume of the liver and number 
of hepatocytes will be reduced. The amount of CCl4 applied (50 µl) leads to necrosis of at 
least 70% of total hepatocytes (Das et al. 2007). Therefore, CCl4-treated animals reconstitute 
the normal liver size by mitosis of (GD AdV-transduced) hepatocytes. With this procedure the 
question was addressed whether putative mammalian origins of replication within the GD Ad 
vector genome can be activated by host cell proliferation. An overview over the experimental 
procedure of the in vivo experiment is shown in [figure 16].  
 
  
 
Figure 16: Experimental procedure for the analysis of the replicative state of GD AdV 
genomes in murine liver. The two photographs were reprinted from Bezerra et al. 1999 with 
modification. 
 
All three groups (GD AdV-, GD AdV + CCl4-treated and control) were monitored for 
human blood coagulation factor IX (hFIX) transgene expression and alanine transferase 
(ALT) levels (Ozer et al. 2007) as indicator of liver toxicity for up to 9 weeks p.i. [figure 17 
and figure 18]. After an initial peak of ALT levels on the first day p.i., these liver enzyme 
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levels stayed within normal range (9-30 U/l) in all non-CCl4-treated animals. CCl4-treated 
mice showed very high levels of serum transaminase (up to 800 U/l) after drug administration 
which declined to normal range within one week [figure 17]. By 9 weeks p.i. murine livers 
were collected to extract genomic and viral DNA. At the time of liver resection, the 
morphology of CCl4-treated livers was pale and abnormal in residual areas, the size of the 
liver was normal (data not shown). Livers of CCl4-untreated mice looked normal. 
 
 
 
Figure 17: Surveillance of liver alanine transaminase levels for determination of liver 
toxicity. Alanine transaminase (ALT) levels were determined in murine serum using a 
commercially available assay (Randox). (U/l) = units per litre; (p.i.) = post infection; (CCl4) = 
carbon tetrachloride. 
 
 
Transgene expression was determined using ELISA (Kay et al. 1995). Transgene 
expression levels before and after CCl4 administration and at the end of the experiment were 
of particular interest. Within the first days after GD AdV transduction, high levels (up to 8000 
ng/ml) of the human blood coagulation factor IX were detectable [figure 18]. These initial 
levels increased during the next weeks, reaching supra-physiological hFIX levels (>10000 
ng/ml). Physiological hFIX levels are ranging from 3000 to 5000 ng/ml. After CCl4-treatment 
a drop of 90% in hFIX levels was seen which stabilised at a lower level (about 1000 ng/ml) 
afterwards. This result is in concordance with earlier experiments (Yant et al. 2002). hFIX 
expression in non-CCl4-treated mice stayed stable throughout the experiment. 
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Figure 18: Human blood coagulation factor IX (hFIX) expression profile in C57Bl/6 
mice. Serum levels of hFIX were determined analysing murine serum by ELISA. Stable 
transgene expression was achieved throughout the experiment in mice treated with GD AdV 
alone (black graph). Note the decrease in hFIX levels after CCl4 administration (grey graph). 
As expected, mock injected mice did not produce human factor IX (DPBS, dashed graph). 
(p.i.) = post infection; (CCl4) = carbon tetrachloride; (DPBS) = Dulbecco’s phosphate 
buffered saline. 
 
 
1.5.1 Investigation of the replicative state of GD AdV genomes in vivo by conventional PCR 
 
First, a conventional PCR was established to evaluate the presence of a specific XhoI 
recognition site within the GD AdV genome. Purified DNA of CsCl-isolated and 
disintegrated particles (1.5x107) was used as templates for PCR. The expected PCR fragment 
(800 bp) was then isolated from the gel, purified and subjected to XhoI digestion. The 
correctness of the PCR-fragment and the presence of the XhoI recognition site were shown by 
bands of 300 bp and 500 bp after digestion [figure 19]. 
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Figure 19: Establishment of a conventional PCR for detection of methylated and un-
methylated XhoI recognition sites. A: Schematic overview over the GD AdV DNA 
fragment amplified. The oligonucleotides (red arrow: For-1700 and blue arrow: U6Rev775) 
and the XhoI recognition site are depicted. B: Agarose gel after PCR and digestion of PCR 
products. (1): The PCR product after digestion with XhoI. The full length fragment (800 bp) 
was cleaved into fragments of 500 and 300 bp. (2): Full length PCR fragment (800 bp). (M) = 
molecular size marker. 
 
 
Next, this PCR was performed with isolated and purified liver DNA of untransduced 
and transduced mice. Five hundred pg of total liver DNA were used for PCR before and after 
XhoI digest. If there was replication of GD AdV genomes, the PCR after XhoI cleavage 
should be negative. However, in all transduced mice (n=8), a specific PCR product was seen 
before and after XhoI treatment [figure 20]. Comparing the intensity of PCR bands before and 
after XhoI digestion, equal amounts of GD AdV DNA were used as starting material for the 
PCR The unmethylated control, the plasmid pAdFTC GD hFIX (500 pg) was cleaved by 
XhoI, showing reduced PCR efficacy. The uninfected control mice (no. 9 and 10) were 
negative for vector DNA. This finding suggests that GD AdV DNA was not replicating in 
quiescent and proliferating murine liver tissue. 
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Figure 20: Conventional PCR of murine hepatic DNA before and after XhoI digest. A: 
PCR before XhoI digest. All transduced mice (1 to 8) show a positive signal for GD AdV 
DNA (800 bp), as expected. DNA of un-transduced control mice generated no signal. CsCl 
purified GD AdV genomes (CsCl GD AdV) serve as positive control in this experiment. B: 
PCR after XhoI digest. All transduced mice (1 to 8) show - still - a positive signal for GD 
AdV DNA (800 bp), demonstrating ineffective XhoI cleavage resulting from maintained 
methylation. The un-methylated plasmid pAdFTC GD AdV, however, was cleaved by XhoI 
resulting in a strongly diminished PCR signal. The weak signals below the 800 bp fragments 
result probably from unused or dimeric oligonucleotides. (M) = molecular size marker. 
 
 
1.5.2 Analysis of the replicative state of GD AdV genomes in murine liver by real-time PCR 
 
To detect low amounts of viral DNA that might have lost methylation due to 
replication, a real-time PCR assay with oligonucleotides that anneal around the specific XhoI 
site within the GD AdV genome was established [figure 21]. Genomic liver DNA was treated 
with XhoI and, as a control, with equal amounts of NcoI. NcoI cleaves GD AdV DNA at 
arbitrary positions but not between the RT-PCR oligo annealing sites detecting XhoI-
cleavage.  
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Figure 21: Schematic outline of the real-time PCR experiment for detection of replicated 
and unreplicated GD AdV genomes. The GD AdV hFIX genome is shown in black. The 
oligonucleotides TaqFor (red) and TaqRev (blue) as well as the specific FAM-TAMRA-
labelled probe (pink) are indicated. The XhoI recognition site is located between the annealing 
sites of the oligonucleotides. The amplified PCR fragment is 102 bp in size. NcoI sites are 
situated at arbitrary positions but of course not between the RT-PCR annealing sites detecting 
XhoI-cleavage (not shown). 
 
To confirm that the methylase/endonuclease-based system is applicable to real-time PCR, 
replication kinetics were performed. 293 cells were transduced with methylated GD AdV at 
MOI 100 and helper virus at an MOI of 10. Helper virus co-infection promotes replication of 
GD AdVs. The double-transduced cells were harvested at the time points indicated, DNA was 
isolated via Hirt protocol, the samples were digested with XhoI or NcoI and the described 
real-time PCR was applied [figure 22]. At 1 h and 6 h post transduction the methylated 
adenoviral input DNA was re-isolated. No difference between XhoI and NcoI digest was 
detectable at the early time points. At 12 h p.i. replication and de-methylation of GD AdV had 
partly begun, indicated by the shift of the crossing point of the XhoI-digested sample to higher 
PCR-cycle numbers [figure 22]. A certain level of methylated input GD AdV DNA was still 
present. In contrast 24 and 48 h p.i., methylated input GD AdV DNA was no longer 
detectable after XhoI-digest, demonstrating that replication promoted by helper virus proteins 
had taken place. Also, the total amount of GD AdV DNA within these samples increased, 
indicated by a shift of the crossing points of the NcoI-digested samples to lower PCR cycle 
numbers. As additional controls, digested unmethylated plasmid DNA (pAdFTC) and CsCl-
purified methylated GD AdV DNA were analysed. Plasmid DNA was completely cleaved 
whereas methylated GD AdV DNA was not. In conclusion, RT-PCR can be used to detect 
unreplicated, partially replicated and completely replicated de-methylated adenoviral DNA. 
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Figure 22: Removal of methylation by replication detected by real-time PCR. 
Investigated were samples at time points 1 to 48 h after transduction of 293 cells with GD 
AdV (MOI 100) + helper virus (MOI 10). Samples were harvested at the time points indicated 
(1 to 48 h), Hirt-extracted and XhoI or NcoI digested, respectively. 200 ng total DNA were 
used for real-time PCR analysis. Controls: pAdFTC, an un-methylated plasmid containing the 
whole GD AdV sequence, CsCl-purified methylated GD AdV DNA. n.d.: not detectable. 
 
 
Next, the replicative state of GD AdV genomes in murine liver was analysed. In both 
animal groups, treated with GD AdV + CCl4 or with GD AdV alone, no difference in XhoI-
digested and NcoI-digested samples was detectable [figure 23]. Thus, the methylated input 
GD AdV genomes did not replicate in quiescent and mitotic hepatocytes. These results 
indicate that persistence of GD AdV genomes is independent of vector DNA replication. 
 
 
2.1 Do rAdV form concatemers and/or circles? 
 
After infection of cells with E4 ORF3/6 double mutants (H5dl1004, ∆E4) [figure 24A], 
viral genomes are linked to one another at its termini, leading to head-to-head, tail-to-tail and 
head-to-tail junctions (Weiden and Ginsberg 1994; Sandler and Ketner 1989; Bridge and 
Ketner 1989; Jayaram and Bridge 2005). To test concatenation of rAdV genomes, pulsed field 
gel electrophoresis (PFGE) was used to resolve the high molecular viral DNA. 
 
  Results 
 63 
 
 
Figure 23: Real-time PCR analysis of the replicative state of GD AdV in murine liver. 
Total murine liver DNA was isolated and digested with XhoI or NcoI, respectively. Two 
hundred ng of total DNA were used for real-time PCR analysis. Group 1: mice receiving 
methylated (M) GD AdV + CCl4 (n=3), group 2: mice receiving methylated (M) GD AdV 
alone (n=4), group 3: mock-infected mice (PBS, n=2). Depicted is the PCR cycle in that the 
exponential amplification phase begins (crossing point). Mean values +/- standard deviations 
are shown. n.d.: not detectable. PBS = phosphate buffered saline; CCl4 = carbon tetrachloride. 
 
 
2.1.1 Detection of ∆E4 concatemers using PFGE 
 
To define the detection limits of this system, dose-dependent studies with the ∆E4 virus 
as a positive control for concatemer formation were performed. 293 cells were infected with 
the ∆E4 virus at MOIs ranging from 200 to 1. Forty-eight hours p.i. cells were harvested and 
viral genomes were analysed by PFGE. Southern blot analysis of the pulsed field gel with a 
radioactively labelled probe specific for the ITR/Ψ sequence of the ∆E4 virus revealed 
concatemer formation at high MOIs (100 to 25) and at least dimeric concatemers were 
detected at an MOI of 6 (figure 24B). At the lowest MOIs (3 and 1) only monomeric 
genomes were detectable. The monomeric genomes as well as the dimeric, trimeric and 
multimeric concatemers are detectable at 35 kb, 70 kb, 105 kb and as higher molecular bands 
(x-times 35 kb), respectively (figure 24B). 
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Figure 24: Pulsed field gel electrophoresis (PFGE) to analyse the molecular status of 
∆E4 mutant virus. A: Schematic representation of the genome of ∆E4 mutant virus. The 
deletion in the E4 region is indicated. B: Sensitivity study for PFGE. Southern-blotted pulsed 
field gel of 293 cells infected with ∆E4 virus at MOIs 100 to 1. Forty-eight h p.i. cells were 
harvested and subjected to the PFGE protocol. Concatemers are detectable down to an MOI 
of 6. At an MOI of 3 and 1 no concatemers are detectable. Negative control: total genomic 
DNA of uninfected 293 cells. 
 
 
2.1.2 Analysis of concatemer formation of GD AdV in PFGE 
 
To test whether GD AdV form concatemers several cell lines were infected with GD 
AdV hFIX [figure 25A]. HEK 293 cells, HeLa cells and hepatic cell lines (Sk-Hep, Huh7, 
murine Hepa 1A) were infected at different MOIs (MOI 100 to 15000) and harvested at 
varying time points (16 h to 72 h). PFGE was used to resolve the high molecular viral DNA 
of GD AdV genomes. After Southern transfer and hybridisation of the blotted membranes 
with a ITR/Ψ- and hFIX-specific probe, only monomers (ca. 30 kb) and no concatemeric 
formation of GD AdV genomes were detectable [figure 25B]. Even at high MOIs (3600 and 
15000) no concatemer formation was observed. This result was independent of the 
multiplicity of infection (MOI), the cell line and the time period of incubation (only 
A 
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experiments with high MOIs and an incubation period longer than 20 h are shown). As a 
positive control DNA of ∆E4 mutant virus (H5dl1004) [figure 24] that shows concatenation 
was used. In contrast to ∆E4 virus but similar to GD AdV, a single, monomeric band running 
at 36 kb for wild type adenovirus was detected [figure 25B]. 
                
 
      
ITR5´- Ψ IgκMAR alphoid repeat DNA ApoE/HCR hAAT-p hFIX minigene ITR -3´
GD AdV hFIX
ITR/Ψ probe hFIX probe  
 
                
 
Figure 25: Pulsed field gel electrophoresis to analyse the molecular status of GD AdV 
hFIX and Ad5 wild type. A: Schematic representation of the GD AdV hFIX genome. The 
liver-specific hFIX expression cassette and stuffer DNA elements are shown. Additionally, 
the ITR/Ψ and hFIX probes used for Southern detection are indicated. B: GD adenoviral 
vector genomes do not form concatemers. Cell lines were infected with GD adenoviral 
vectors for up to 72 h. 293 cells infected with ∆E4  virus at an MOI of 400 for 48 h (1), 293 
cells infected with ∆E4  virus at an MOI of 200 for 24 h (2), Sk-Hep cells transduced with GD 
AdV at an MOI of 10000 for 48 h (3), 293 cells transduced with GD AdV at an MOI of 10000 
for 20 h (4), 293 cells transduced with GD AdV at an MOI of 15000 for 20 h (5), genomic 
DNA of uninfected 293 cells (6), 293 cells infected with Ad5 wt at an MOI of 100 for 40 h 
(7). After pulsed field gel electrophoresis the GD AdV genomes were detected in a 
monomeric conformation as bands of 28 kb. The monomeric wt genome is observable as a 
prominent band of 35 kb (7). The positive control was provided by the ΔE4 mutant 
(H5dl1004) that showed multimeric genome concatenation at 35, 70 and 105 kb (1 and 2) in 
HEK 293 cells. As an additional control uninfected 293 cells were used (6). 
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2.1.3 Discrimination between GD AdV genomes and helper virus genomes 
 
Usually preparations of GD AdV contain approximately 0.02 to 0.1% helper virus 
contamination (Palmer and Ng 2003; Puntel et al. 2007). Since the results from the 
hybridisation with the terminal probe do not distinguish between helper virus genomes and 
GD AdV genomes and the MOIs used are high, GD AdV genomes were specifically detected, 
using an hFIX-specific probe that detects only GD hFIX vector DNA [figure 26A, cf. figure 
25A]. After stripping of the membrane, hybridisation was performed with the ITR probe, 
visualising ∆E4 concatemers, Ad5 wt genomes and GD AdV hFIX (+ helper virus) genomes 
[figure 26B]. It was found that the amount of isolated DNA is similar comparing ∆E4, Ad5 
wt and GD AdV genomes. Furthermore, the bands of the hFIX and ITR probes show similar 
intensity, suggesting that contamination with helper virus is low.  
                              
Figure 26: Discrimination between GD AdV, Ad5 wt and ∆E4 genomes. The same 
Southern-blotted gel was hybridised with probes against hFIX (GD hFIX-specific, A) and 
ITR (B), respectively. 293 cells infected with ∆E4 at MOI 100 for 24 h (1). 293 cells infected 
with Ad5 wt at MOI 100 for 24 h (2). Genomic DNA of 293 cells (3). 293 cells infected with 
GD AdV at MOI 10000 for 24 h (4). Note that the total amount of isolated DNA is similar 
comparing ∆E4, Ad5 wt and GD AdV genomes. Furthermore, the bands of the hFIX and ITR 
probes show similar intensity, suggesting that contamination with helper virus is low. 
 
 
2.2 PCR assay for detection of linked adenoviral vector genomes.  
 
To investigate the potential formation of concatemers in more sensitive way and to 
analyse the possibility of circularisation of recombinant adenoviral vector genomes, a PCR 
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specific for concatenated and circular genome conformations was developed. Using this 
approach, head-to-tail concatemers, head-to-tail circular monomers, tail-to-tail or head-to-
head concatemers can be detected. If neither concatemers nor circular monomers are present, 
no PCR-product is generated [figure 27]. 
 
 
 
Figure 27: PCR design for detection of concatemers and circular monomers of gene-
deleted adenoviral vector genomes, ∆E4 as well as 1st generation vector (∆E1/E3) 
genomes. Two oligonucleotides that are specific for the 5´-end of adenoviral DNA (Rev436, 
black arrow) and the 3´-end of the GD AdV genome (For-1700 or H5dl1004For35585Circ, 
grey arrow) result in products of indicated sizes and detect head-to-tail concatemers or head-
to-tail circular monomers, respectively (A and B). Tail-to-tail or head-to-head concatemers 
can be detected with a PCR using forward primer (grey) or reverse primer (black) alone. The 
respective product sizes are individually indicated (C and D). If neither concatemers nor 
circular monomers are present, no PCR-product is generated, as drafted in (E).  
 
 
2.2.1 Determination of the detection limits of this PCR system 
 
To define the detection limits of this PCR, dose-dependent studies with ∆E4 virus were 
performed. 293 cells were infected with this virus at MOIs ranging from 200 to 1 [cf. figure 
24B]. For the PCR, DNA was isolated by Hirt extraction. After PCR a smear of differently 
joined concatemers was detected starting at an MOI of 3 [figure 28A]. Therefore, the PCR 
assay was more sensitive than the PFGE [cf. figure 24B]. At high MOIs (best visible at MOI 
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200) in addition to the smear two bands were visible indicating that predominant molecular 
forms of linkage of recombinant viral genome ends may exist. 
 
2.2.2 Analysis of ∆E4 concatemers obtained by PCR 
 
To prove that the smear obtained in the PCR above [figure 28A] consists of differently 
joined ∆E4 concatemers, the resulting DNA fragments were cloned into the pCRBluntIITopo 
plasmid (Invitrogen). Subsequently, 15 clones were selected, plasmids were isolated and the 
inserted DNA fragment was analysed by DNA-sequencing. It was found that each sub-clone 
was ∆E4-derived and showed a different sequence at its concatemeric junctions with large (up 
to 750 bp) or small deletions (down to 70 bp) in the ITR and/or Ψ regions [figure 28B]. Thus, 
it was concluded that the smear on the gel consists of a variety of differently joined ∆E4 
concatemers. 
 
2.2.3 Sensitivity assay for concatemer and control-of-infection PCRs 
 
To determine the minimal amount of concatemeric DNA necessary for detection, the 
Hirt-extracted sample of 293 cells infected with ∆E4 at MOI of 3 [cf. figure 28A] was 
serially diluted. Subsequently, the concatemer and control-of-infection-PCRs were performed. 
The detection of linear genomes was possible to a 10-5 dilution (4.2 pg). The concatemer PCR 
was 10 fold less sensitive and a signal was detectable to a 10-4 dilution (42 pg) [figure 29A]. 
Furthermore, the number of ∆E4 genomes present in the samples was determined by qPCR. It 
was found that 237 copies (in the 10-5 dilution) generate a signal in the linear control-of-
infection PCR. 2730 copies (in the 10-4 dilution) are needed to detect concatemers [figure 
29B]. 
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Figure 28: Concatemer detection and molecular characterisation in ∆E4 mutant virus. 
A, upper panel: PCR-sensitivity study in ∆E4 mutant virus. 293 cells were infected with ∆E4 
virus at MOI 200 to 1. 48 h p.i. cells were harvested and subjected to Hirt extraction. PCR 
with oligonucleotides Rev436 and H5dl1004For reveals concatemers down to MOI 3 on an 
agarose gel. Controls: H2O - no template, 293 gen. DNA - genomic DNA of uninfected 293 
cells, M = molecular size marker. Bands that are below the smallest marker band (250 bp) 
represent no PCR product but unused oligonucleotides and oligonucleotide dimers, 
respectively. A, lower panel: Control of viral infection of the samples shown in the upper 
panel. PCR was performed with oligonucleotides Rev436 and Ad5ITRfw1-24. All virus-
infected cells show a specific band at 436 bp. Negative controls: H2O - no template and 
genomic DNA of uninfected 293 cells. B: Molecular characterisation of the DNA junctions at 
the ITRs after infection with the ΔE4 virus. Representative examples are shown. The ΔE4 
genome is schematically drawn as black bar. Concatemeric junctions are shown as grey 
arrows with its respective position in base pairs. The type of each concatemeric junction is 
indicated. Deleted regions are represented as dotted line. 
B 
436 bp 
500 bp 
1000 bp 
250 bp 
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Figure 29: PCR-sensitivity for concatemer detection in ∆E4 mutants. Serial dilutions (10-1 
to 10-5) of Hirt-extracted genomic DNA of 293 cells infected with ∆E4 mutant virus at an 
MOI of 3 were subjected to PCR. A, left side: Concatemer PCR with oligonucleotides 
Hdl1004circleFor and Rev436 resulting in the typical concatemeric smear. A, right side: 
Control-of-infection-PCR using oligonucleotides Ad5ITRfw1-24 and Rev436 generates a 
product of 436 bp. B: Quantification of the ∆E4 genome copy number by qPCR. The same 
samples as in A were used for qPCR with oligonucleotides Ad5ITRfw1-24 and Rev436. 
 
 
2.3 Investigation of concatemer and circle formation in GD AdV and ∆E1/E3 AdV genomes 
in cell culture 
 
To analyse the molecular status of GD AdV and ∆E1/E3 AdV genomes, HEK 293 cells were 
infected at an MOI of 1000 and 50, respectively. DNA was isolated and the 
circle/concatemer-specific PCR was performed. In contrast to the infection control using the 
∆E4 virus, no PCR product was obtained for both, GD AdV and ∆E1/E3 AdV DNA 
molecules [figure 30 and figure 31].   
 
A 
B 
  Results 
 71 
                         
Figure 30: No concatemer formation of GD AdV genomes in vitro. A: numerous host cell 
lines were transduced with GD AdV. Purified DNA was analysed by PCR. Controls: H2O - no 
template, 293 gen. DNA – genomic DNA of uninfected 293 cells. Positive circle control: 
pAdFTC hFIX XNotI + ligated - plasmid pAdFTC GD hFIX cut with NotI and relegated (see 
also Appendix 3). Positive control for concatemer formation: 293 ∆E4 - 293 cells infected 
with ∆E4 mutant virus. B: control-of-infection-PCR. Monomeric GD AdV genomes are 
detectable in all transduced cell lines. (M) = molecular size marker. 
 
 
To analyse whether concatemer formation is dependent on the infectious dose, HEK 
293 cells, HeLa cells, and other hepatic cell lines (Sk-Hep, Huh7, murine Hepa 1A) were 
infected at an MOI of up to 15000. Low molecular weight DNA was isolated by Hirt 
extraction and the concatemer/circularisation assay was performed. It was found that, in 
contrast to the positive controls, no concatenated or circular genome conformations were seen 
after 72 h of viral incubation in vitro (data not shown). In concordance with the PFGE 
analysis this finding was independent of the cell type used. This finding suggested that linear 
monomers are the predominant molecular form of GD adenoviral vectors in vitro. 
Altoghether, these results indicate that the incoming recombinant adenoviral DNA molecule 
was not subject to the double strand break repair (DSBR) machinery of the host cell in vitro.  
A 
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Figure 31: ∆E1/E3 AdV genomes do not form circles or concatemers in vitro. HEK 293 
and HeLa cells were infected with 1st generation vector (∆E1/E3) at an MOI of 50, Sk-Hep, 
Huh7 and Hepa 1A cells were infected with 1st generation vector at an MOI of 1000 for 72 h 
(lanes 2 - 6). 293 cells infected with ∆E4 virus at an MOI of 50 serves as positive control for 
concatemerisation (lane 1). PCR was carried out with oligonucleotides H5dl1004For and 
Rev436. Samples running on lanes 7 to 11 represent the infection controls for the samples 
shown on lanes 2 to 6. This control-of-infection-PCR was carried out employing oligos 
Rev436 and Ad5ITRfw1-24 to detect 1st generation vector DNA as a band of 436 bp. (M) = 
molecular size marker. 
 
 
2.4 Analysis of the molecular status of GD AdV genomes in quiescent and cycling cells in 
vivo.  
 
To analyse whether concatemers and/or circular monomers are formed in murine liver, 
7.5x109 transducing units of the GD AdV hFIX were injected into the tail vein of C57Bl/6 
mice (n=8). In addition to the examination of the molecular status of viral genomes in 
quiescent/slowly proliferating hepatic tissue, the question was addressed whether the 
induction of liver cell proliferation influences the molecular forms of GD AdV DNA. In 
previous studies it was demonstrated that the expression profile of hepatocytes significantly 
changes during induction of mitosis (Fukuhara et al. 2003). This may lead indirectly to 
conformational changes of adenoviral DNA molecules. Therefore, carbon tetrachloride (CCl4) 
was intraperitoneally administered six weeks after viral infection (n = 3). Mice treated with 
GD AdV + CCl4 were killed seven weeks (mouse no. 1) or nine weeks post injection (mouse 
no. 4 and 5). Another group of mice received the GD AdV (n=5) alone and murine livers were 
isolated five weeks (no. 2 and 3) and nine weeks (no. 6, 7 and 8) post injection.  As a negative 
control group two mice (no. 9 and 10) were mock-infected with Dulbecco´s phosphate 
buffered saline (DPBS). Animals were killed at the given time points and total genomic liver 
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DNA including GD AdV DNA was isolated. This purified DNA was subjected to a PCR 
protocol as described above to detect concatenation or circularisation of GD AdVs [figure 
27]. In concordance with the in vitro results, no concatenated or circular vector genomes were 
found in any of the animals transduced with GD AdV [figure 32A]. Figure 32B shows the 
infection control PCR. No PCR product was obtained in the negative control group (mouse 
no. 9 and 10). Thus, the results indicate that linear monomers are the predominant molecular 
form of GD adenoviral vector genomes also in vivo. 
 
   
 
Figure 32: Neither concatemers nor circular monomers of gene-deleted adenoviral 
vector genomes are detectable by PCR in murine liver. A: C57Bl/6 mice were infected 
with 7.5x109 transducing units of the GD adenoviral vector (n = 8, lanes 1 to 8). The negative 
and uninfected control group received PBS alone (lane 9 and 10). After isolation of murine 
genomic liver DNA, PCR for GD AdV was performed with oligonucleotides Rev436 and For-
1700. Re-ligated plasmid pAdFTC and 293 cells infected with ∆E4 mutant represent the 
positive controls. M = molecular size marker, H2O = water control. Treatment with CCl4 to 
induce hepatic cell cycling is indicated with (+). B: Infection controls for the samples shown 
in figure 37A. All PCR-reactions were carried out with the oligonucleotide Rev436 (black in 
figure 26) and an additional oligonucleotide that anneals at the very end of the viral ITR (bp 
1-24 Ad5ITRfw1-24). This PCR reveals the presence of viral vector DNA in all infected mice 
(numbers 1 to 8) resulting in a band of 436 bp. DPBS = Dulbecco’s phosphate buffered saline, 
CCl4 = carbon tetrachloride. 
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D Discussion 
 
 
Recombinant adenoviral vectors (rAdV) are a promising gene therapeutic tool for 
efficient transduction and long-term transgene expression with limited side effects. We and 
others (Kreppel et al. 2002; Ehrhardt and Kay 2002; Brunetti-Pierri et al. 2007; Jozkowicz 
and Dulak 2005) showed that after injection of a single dose of gene-deleted adenoviral vector 
(GD AdV) particles the viral genome is maintained. Even after induction of cell cycling of the 
host cell in murine liver the GD AdV DNA molecule is more stable than non-viral DNA 
(Ehrhardt et al. 2003). Therefore, one part of this study was to reveal the mechanism of 
persistence of rAdVs. Several mechanisms that potentially could lead to this persistence have 
been discussed (Jager and Ehrhardt 2007; Kreppel et al. 2002; Ehrhardt et al. 2003). The 
rAdV genome may (i) replicate episomally, (ii) form concatemers that were shown to be 
predominantly responsible for persistent transgene expression in the context of rAAV. 
Furthermore, (iii) circularisation of rAdV DNA might improve vector DNA maintenance, 
which was shown for example for members of the Herpesviridae. Herpes simplex virus 1 
persists in circular conformation in non-dividing host cells without replication (Roizman and 
Sears 1996). The Epstein-Barr-Virus genome on the other hand, is maintained in a circular 
conformation in dividing lymphocytes with simultaneous replication (Kieff 1996). 
Concatemeric rAdV DNA could be more persistent during host cell mitosis due to a 
multiplication of stabilising effects of one monomer (centromeric region, matrix attachment 
region, nuclear retention signals) within one large multimeric molecule. Moreover, if the 
vector genome replicates as a linear DNA molecule without telomeric regions, concatemers 
could be more persistent because this large molecule only gradually becomes shorter at its 
ends after each replication cycle, and therefore, concatemers would have an extended half-life 
compared to single genomes. Second, circularisation of vector genomes might play an 
important role for episomally replicating vectors because the difficulties associated with 
replication of linear DNA would be circumvented.  
In the present study these questions were - at least in part – addressed by showing that the 
formation of concatemers is not responsible for vector genome persistence and transgene 
expression over a long period of time [figures 25, 30 and 32]. Also circularisation of 
recombinant AdV genomes was excluded [figure 30 and figure 32]. Moreover, it was found 
that GD AdV genomes are defective in replication in vitro and in murine liver. This suggests 
that the listed mechanisms can not explain rAdV genome persistence. 
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1.1 GD AdV genomes are not replicated in vitro and in vivo 
 
The GD AdV contains a putative mammalian origin of replication (ori) within its 
centromeric region (Krysan et al. 1993; Ehrhardt and Kay 2002). We proposed that this 
mammalian ori could be activated by the host cell replication machinery to prolong the 
vector’s half-life. However, in cell culture studies as well as in replication-activated and 
quiescent liver tissue no replication of GD AdV genomes was seen. 
Cell proliferation of murine hepatocytes was induced by injection of the liver toxic 
halogenated hydrocarbon CCl4. It is not possible to monitor the number of removed and 
subsequently restored hepatocytes. Therefore, the surveillance of alanine transferase (ALT) 
and human blood coagulation factor IX (hFIX) transgene expression levels was performed as 
control mechanisms for the animal experiments. The CCl4 toxicity profile that was compiled 
in the present study showing transient elevation of ALT levels upon CCl4 application [figure 
17], is confirmed by data already published (Das et al. 2007; Bezerra et al. 1999). At the 
given dose, at least 70% of affected hepatocytes are removed from the liver and strong cell 
cycling of the remaining hepatocytes was induced (Das et al. 2007). This hepatocellular 
proliferation should have activated potential origins of replication in the GD AdV genome.  
Furthermore, it was reported that the hFIX expression levels drop because of CCl4-induced 
hepatic injuries and loss of episomal GD AdV genomes (Yant et al. 2002). This finding was 
in concordance with the present study in which a similar decrease of hFIX expression levels 
post CCl4 treatment was detected. This finding further suggests that a significant number of 
hepatocytes was destroyed. The removed hepatocytes, however, were subsequently replaced 
by liver regeneration, such that at the ending of the experiment the size of the organ looked 
normal (data not shown).  
GD AdV genome replication would be more effective with circular or concatemeric 
vector DNA than with a linear monomeric genome. Our studies on circularisation and 
concatenation, however, showed that GD AdV genomes stay in linear monomeric 
conformation and argue against episomal replication (Jager and Ehrhardt 2008, submitted).  
The real-time PCR assay is sensitive in detecting unmethylated replicated genomes. Yet, 
one cannot completely exclude that some low level of replication takes place. Another 
possibility may be that a threshold level is required for replication of GD AdV. This is 
indicated by the dose-dependent replication of Ad5 wt in Sk-Hep-1 cells was detected [figure 
14]. At low multiplicity of infection (MOI 100) no replication was detected at high MOI 
(MOI 3000), however, there was removal of methylation from Ad5 wt genomes. Accordingly, 
Jayaram and Bridge (2005) demonstrated a severe replication defect of ∆E4 mutants relative 
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to Ad5 wt at low MOI (MOI 3) that could partly be rescued by administration of higher MOI 
(MOI 30). 
To control tropism and transduction efficacy of GD AdV hFIX, luciferase life-imaging 
experiments were performed. GD AdV luc transduced the murine liver [figure 7]. Although 
this is not a direct proof that GD AdV hFIX also transduces the liver with the same efficiency, 
we suppose that both GD AdV possess similar transduction rates, since both vectors possess 
identical capsids derived from the same Ad5 helper virus. An efficient transduction rate of 
hepatocytes using Ad5-derived vectors has previously been reported (Toietta et al. 2005; 
Morral et al. 1998; Brunetti-Pierri et al. 2006). Furthermore, the administered vector dosages 
were similar for both vectors (GD AdV hFIX 7.5x109 and GD AdV luc 1x1010, respectively). 
Moreover, at the time point of liver resection (5 to 9 weeks p.i.), hFIX expression was high 
[figure 18]. In comparison, the expression of luciferase - driven by the same liver-specific 
enhancer/promoter construct as hFIX - in week seven was high as well [figure 7B]. However, 
one cannot state that the course of transgene expression and the vector’s tropism are identical 
in the different murine strains (Balb/c or C57Bl/6, respectively) used (Mills et al. 2000). 
To avoid adverse events in vivo, it is useful to apply the minimal vector dose that 
achieves maximum therapeutic effect. In the in vivo experiments using GD AdV hFIX, 
approximately 75 vector genomes per hepatocyte were applied (1x108 hepatocytes per murine 
liver, administered dose 7.5x109 vector particles). This dose, sufficient to transduce the whole 
liver and to obtain high levels of transgene expression, was well tolerated (Yant et al. 2002; 
figures 17 and 18). At this dose GD AdV is replication-inactive [figures 20 and 23]. The 
small percentage of contaminating ∆E1/E3 helper virus that is copurified during vector 
preparation (Palmer and Ng 2003, Appendix figure 2), does not in trans influence replication 
of the GD AdV DNA molecule in murine liver. Replication of GD AdV genomes driven by 
helper virus proteins might have been possible because the helper virus provides most genes 
(besides E1) essential for genome replication. 
Using a 1st generation vector lacking E1, Nelson and Kay (1997) showed that there are 
differences in the replication profile of this type of vector in vitro and in vivo. Notably, their 
1st generation vector was able to replicate in human huH7 cells and primary murine and 
macaque hepatocytes. In the liver of C57Bl/6 mice, the authors did not detect replication. 
Lieber et al. (1997b) speculated that low amounts of E2 proteins produced by 1st generation 
vectors are necessary for stabilising adenoviral mini-vectors that are only 9 kb in size and lack 
all viral coding sequences. In contrast, Hodges et al. (2000) reported that lack of E2 proteins 
which renders the virus replication deficient, did not affect DNA maintenance of a 2nd 
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generation vector. Since this 2nd generation adenoviral vector was found to persist for several 
months despite the lack of its replication machinery, these findings support the data of the 
present study implying that replication is not essential for vector genome persistence. 
Therefore, other features like centromeric regions, nuclear retention signals and/or MARs 
have to account for episomal GD AdV genome maintenance.  
In summary, it was demonstrated that input GD AdV genomes persist without 
replication in vitro and in vivo. This finding adds to the already improved safety profile of GD 
AdV compared to earlier vector generations. 
 
 
1.2 rAdV genomes do not form concatemers or circles 
 
The infection with Ad exposes the host cell to exogenous linear dsDNA and leads to the 
activation of cellular double strand break repair (DSBR) proteins that normally respond to 
damaged chromosomal DNA (Boyer et al. 1999). The proteins E4 34 kDa and E4 11 kDa 
prevent the DSBR system from “repairing” the viral genome by marking the DSBR proteins 
of the Mre11/Rad50/Nbs1 complex for degradation (Stracker et al. 2002). Therefore, the 
genomes of ∆E4 mutants are connected to one another during the viral replication process 
leading to multimeric chains of adenoviral DNA.  
It was found in the present study that first generation ∆E1/E3 AdV recombinant 
adenovirus lacking the early genes E1 and E3 end up as linear monomers in the host cell. This 
observation might be due to sufficient levels of E4 proteins expressed from the ∆E1/E3 AdV 
virus genome inhibiting the DSBR machinery in transduced cells. Because concatemers were 
not detected, the hypothesis that GD AdV genomes are affected by the DSBR system like 
∆E4 mutant virus could not be confirmed. This finding raises the question, if other proteins 
involved in the concatemer formation are provided by ∆E4 mutants but not by GD AdV. Such 
proteins – both viral (pTP, Ad-Pol, DBP) and cellular (Oct1, NFI) (de Jong and van der Vliet 
1999) – that interact at the ITRs of the adenoviral genome could enhance the recruitment of 
DSBR proteins to the viral termini. Another possibility might be that an amplification of the 
viral genome is necessary for activation of DSBR proteins. ∆E4 mutants can amplify their 
genome by E1 and E2 proteins and cellular factors. This leads to a very high amount of viral 
DNA inside the host cell that is subsequently concatenated [figures 24, 28 and 29]. Until the 
present study, it was not known if GD AdV show any replication activity independent of the 
viral E1 and E2 proteins. Replication might have been possible because the GD AdV used in 
the present study contains DNA sequences that code for potential mammalian origins of 
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replication (Krysan et al. 1993; Ehrhardt and Kay 2002).  However, our results indicate that 
GD AdV are not able to replicate [figures 30 and 32]. The idea that viral replication is a 
prerequisite for activation of the DSBR system, is also supported by the finding that the 
induction of the host cell DNA damage response is dependent on Herpes virus replication. 
Replication defective Herpes simplex virus or non-permissive host cells like neurons fail to 
elicit the cellular DNA repair system (Lilley et al. 2005; Shirata et al. 2005). This suggests 
that the formation of concatemers is a more complex process.  
A comparative overview over the proposed molecular forms of GD AdV genomes, ΔE4 
adenovirus, ∆E1/E3 AdV, and wild type adenovirus is provided in figure 33. Thus, results 
presented in this study differ from other gene transfer systems based on linear DNA or 
recombinant AAV. For these vector systems, linear DNA introduced into the cell provides a 
substrate for the DSBR system. In this regard, GD AdV that also enters the cell as a linear 
monomer, seems to be unique because it persists as a linear monomer. Perhaps the TP which 
is covalently bound to the ITRs or cellular proteins interacting with the ITRs prevent 
concatemer formation by interactions with the DSBR system. 
 
 
Figure 33: Proposed molecular forms of gene-deleted and other adenoviruses. (+) = 
detectable, (-) = not detectable, (?/n.d.) = unknown/not determined. GD AdV are exclusively 
present as replication-inactive linear monomers. 
 
Interestingly, the junctions between individual ∆E4 virus genomes are very diverse [figure 
28]. This phenomenon can not be explained by homologous recombination (HR) or simple 
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ligation of vector genome termini. As it is known that non-homologous end joining (NHEJ) 
leads to random deletions at the site of the DNA junctions (Allen et al. 2003), it is likely that 
NHEJ may represent the predominant mechanism of ∆E4 concatemer formation. Since ∆E4 
mutants show a severe replication defect compared to wild type Ads at low MOIs (MOI 3) 
(Jayaram and Bridge 2005), one could speculate that hardly any replication takes place at 
MOIs lower than 3. Thus, it may have been impossible to detect concatemers in the PCR 
assay at an MOI of 1. However, the PCR assay is sensitive enough to trace low amounts of 
concatemers. Therefore, it was concluded that the predominant molecular form of GD AdV is 
the linear monomer.                                       
∆E4 mutants show a reduced stability of late mRNA (Halbert et al. 1985, Sandler and 
Ketner 1989). This phenomenon could be explained by a disorganisation of the normal 
coordination of transcription and export of viral mRNA by genome concatenation. The DNA 
replication centers in ∆E4 mutants are unusually large and contain aggregations of the 72 kDa 
DNA binding protein (Bridge et al. 2003). Additionally, this disorganisation could be caused 
by the loss of a stabilising or transport function of E4 proteins in ∆E4 mutants. Since GD 
AdV genomes do not form concatemers and are probably not organised in replication centers, 
the expression of transgenes from the GD AdV is not negatively affected by aggregate 
formation. This is important because GD AdV was designed to deliver therapeutic transgenes 
to correct or attenuate a genetic disease in a long-term manner. Ehrhardt and Kay (2002) 
demonstrated that the same vector used in the present study is capable to reach 
supraphysiological transgene expression levels driven by a liver-specific promoter for several 
months. This finding could be confirmed in the present study [figure 18]. 
One might have speculated that concatemer formation or circularisation of GD AdV 
genomes is even higher than in ∆E4 mutants, since in contrast to ∆E4 mutant-infected cells 
the normal cell cycle control is not disturbed by GD AdV infection. ∆E4 mutants express the 
E1B protein that interferes with p53, a crucial tumour suppressor protein regulating cell cycle 
progression (Russell 2000). In the GD AdV-infected cell, the p53 protein could arrest the cell 
cycle between G1 and S phase. By this arrest the cell gains the opportunity to repair 
chromosomal double strand breaks and to join GD adenoviral linear DNA. This, however, is 
not the case. 
The results of the present study are not in line with those of Kreppel and Kochanek 
(2004) who found circular molecules of gene-deleted high-capacity (HC) adenoviral vector. 
They discovered spontaneous circularisation of the HC vectors without Flp-mediated 
circularisation. Kreppel and Kochanek (2004) used three different HC vectors which were 
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found to form circular molecules to a varying degree. The vector encoding EBNA1/oriP 
showed the best results in this respect. Thus, the vector’s backbone might have yet unknown 
significant features that support its circularisation. Our GD AdV apparently does not have 
such elements.  
The positive control for circular GD AdV genomes that was used in the present study 
was generated by ligation. This resulted in a DNA-fragment of defined size (2136 bp) after 
PCR [figure 30]. The variety of differently joined concatemers of ∆E4 mutant genomes, 
however, was detected as a smear consisting of an undefined variety of PCR products, 
suggesting that NHEJ occured. Perhaps circular conformations of DNA are also generated by 
NHEJ, leading to a variety of differently connected DNA circles. The circular forms that were 
reported by Kreppel and Kochanek (2004), however, were apparently generated by ligation or 
HR, since the authors detected defined PCR fragments of a constant size.  
Taken together, it was demonstrated that GD adenoviral vectors are present as linear 
monomers within the host cell. Thus, the reason for vector genome persistence requires 
further investigation. 
In the future it will be of interest to analyse other potential mechanisms of GD AdV 
persistence inside the host cell. A centomeric function of the GD AdV genome or a nuclear 
retention signal might play important roles. We expect that further understanding of GD AdV 
DNA maintenance will not only contribute to our understanding of the molecular persistence 
of adenoviral vectors as an important gene therapeutic agent but will also help to improve 
other viral and non-viral vector systems. 
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F Appendix 
 
 
1. Molecular size marker 
 
 
 
Appendix figure 1: peqGOLD 1 kb DNA marker. This 
molecular size marker was used for approximate 
determination of DNA fragments on 1% agarose gels. The 
size of the single bands is indicated. Size range: 250 bp to 
10000 bp. Three enhanced bands (1000, 3000 and 6000 bp) 
help orientation. Reprinted from peqlab Biotechnologie 
GmbH. 
 
 
 
 
 
 
 
 
2. Characterisation of virus and vector preparations 
 
2.1 Determination of infectious titres and total genomes by real-time PCR 
 
Infectious genomes and total genomes were determined by quantitative real-time PCR 
(qPCR). It was found that the number of total genomes detected by qPCR is generally lower 
than the number of total genomes calculated by OD260 measurement. This is true for all three 
analysed virus and vector preparations (GD AdV, ∆E4 and Ad5 wt). As expected, the number 
of infectious genomes is again only a fraction of total genomes [Appendix figure 2]. 
Importantly, the relations between these fractions (total titre:infectious titre, OD260 titre:total 
titre and OD260 titre:infectious titre) show similar tendency for each virus and vector 
preparation, respectively. Therefore, using OD260 titres for calculation of the MOI for 
transducing host cells instead of infectious titres, as done in the present study, does not 
influence the relative amounts of delivered genomes. The total amount of readily transducing 
particles, however, has to be corrected to a lower level.  
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2.2 Determination of the helper virus contamination in GD AdV preparations by 
quantitative PCR 
 
Since it is of useful to know, whether GD AdV could be influenced by the helper virus 
that is inevitably co-purified during vector preparation and the MOIs used in some of the 
experiments are high, the level of helper virus contamination was determined by qPCR. 5 µl 
of CsCl purified the GD vector preparation were used for helper virus titre determination. 
Helper virus was specifically detected by a probe against the late protein 3 (L3). The 
contamination of GD vector with helper virus lays at 0.09% compared to the number of total 
particles [Appendix figure 2]. This amount is well in the range reported by others (Puntel et 
al. 2007). 
 
    
 
 
 
Appendix figure 2: Determination and comparison of GD AdV hFIX, ∆E4 and Ad5 wt 
titres by qPCR. Physical titres were determined by OD260 measurements. Molecular titration 
using qPCR was carried out to measure helper virus contamination (L3 probe), infectious and 
total particles. 5 µl of CsCl-purified GD vector were used for helper virus titre determination. 
Total particles and infectious particles were determined analysing 200 fg of Hirt-extracted 
DNA of infected (MOI 10) 293 cells. Titres indicated represent the particle/genome number 
per µl. All MOI indicated in the present study, however, relate to titre determinations by 
OD260 measurements.] 
 
 
2.3 Comparison of the infectious titre of ∆E4 mutants and GD AdV by Southern blot 
 
To control that similar amounts of ∆E4 and GD AdV genomes were administered, 293 
cells were infected with either virus at OD260 MOIs of 1, 11 and 33. Cells were harvested after 
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4 h of incubation with trypsin. Thirty µg of total DNA were analysed on a Southern blotted 
gel. The intensity of the respective band indicates the relative infectious titres. We found 
that ∆E4 and GD AdV show similar titres at the respective MOI [Appendix figure 3]. 
 
                          
331110
32 kb
MOI
∆E4 GD ∆E4 GD ∆E4 GD
  
 
Appendix figure 3: Comparison of infectious ∆E4 and GD AdV titres by Southern 
blotting. 293 cells were infected with virus or vector at OD260 MOIs of 1, 11 and 33. The 
cells were harvested after 4 h of incubation with trypsin and genomic DNA was isolated. 
Twenty µg of total genomic DNA were analysed on a Southern blotted gel. 
 
 
3. Establishment of a PCR assay for detection of circular GD AdV genomes 
 
To provide a positive control for vector circularisation, CsCl-purified GD AdV DNA 
was extracted with phenol:chloroform:isoamylalcohol. This leads to removal of capsid 
proteins and the terminal protein (TP). After precipitation of GD AdV DNA, the genome was 
ligated with T4 ligase. The ligase was heat-inactivated. As an alternative, the GD AdV 
genome was released from pAdFTC GD hFIX with NotI and ligated subsequently. The ligase 
was heat-inactivated. These ligated DNA were used as template for PCR. Using the 
oligonucleotides For-1700 and Rev436, a PCR product of 2136 bp indicates the presence of 
circular GD hFIX genomes [Appendix figure 4A]. As controls, different combinations of 
oligonucleotides were used to verify the specificity of the PCR [Appendix figure 4B]. In 
conclusion, the circular conformation of GD AdV genomes can be specifically detected as a 
2136 bp amplification product. 
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Appendix figure 4: Establishment of a PCR assay for detection of circular GD AdV 
genomes. A: Schematic overview over the circular PCR. Oligonucleotides are indicated as 
arrows (For-1700 and Rev436). B: Agarose gel after PCR. pAdFTC GD hFIX DNA was 
cleaved with NotI to release the GD AdV DNA. This released GD AdV DNA was 
subsequently ligated. Using oligonucleotides For-1700 and Rev436, the circular pAdFTC GD 
hFIX DNA can be detected as a band of 2136 bp (1). Using oligonucleotides Ad5ITRfw1-24 
and Rev436, the left terminus of the construct is amplified (436 bp) (2). Utilising 
Ad5ITRfw1-24 and For-1700, the right terminus is amplified (1700 bp) (3). No template 
control (4). Applying the same oligonucleotides For-1700 and Rev436 on un-ligated, linear 
GD AdV DNA, no PCR band is visible, further confirming the correctness of the generated 
circular PCR products (5). M = molecular size marker.  
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4. Plasmid maps 
 
                      
                                          
Appendix figure 5: pGL3 ApoE HCR hAAT luc. This plasmid was used for the 
construction of GD AdV expressing firefly luciferase. pGL3 ApoE HCR hAAT luc was 
constructed by cloning of the liver-specific promoter/enhancer region ApoE HCR hAAT in 
front of the luciferase gene. ApoE HCR = Apolipoprotein E, hepatic control region 
(enhancer), hAAT = human alpha-1-antitrypsin promoter, luc = luciferase, AmpR = ampicillin 
resistance gene. 
                 
Appendix figure 6: pHM5 ApoE HCR hAAT luc. This plasmid was used for 
construction of GD AdV luc. Luciferase is under control of the liver-specific 
promoter/enhancer region ApoE HCR hAAT. This plasmid mediates resistence against 
kanamycin. Relevant recognition sites for endonucleases are indicated. 
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